BORISSEPESIBORIS SEPESI9745SEPESI, BORISAssistant Professorprns:coAuthorOfcoauthor ofFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson1400 Pressler StHouston77030-4008TXAuthorship 185350220881767Gaur P, Sepesi B, Hofstetter WL, Correa AM, Bhutani MS, Vaporciyan AA, Watson TJ, Swisher SG, Members of the MD Anderson Esophageal Cancer Group and the University of Rochester School of MedicinAnnals of surgeryA clinical nomogram predicting pathologic lymph node involvement in esophageal cancer patients. Ann Surg. 2010 Oct; 252(4):611-7.Ann Surg2010-10-01T00:00:002010A clinical nomogram predicting pathologic lymph node involvement in esophageal cancer patients.GI Medical OncologyRadiation OncologyThoracic & Cardiovascular SurgeryThoracic Head & Neck Medical OncologyTranslational Molecular PathologyMD AndersonJOE YCHANGJOE Y CHANG8639CHANG, JOE YProfessorARA AVAPORCIYANARA A VAPORCIYAN8772VAPORCIYAN, ARA AProfessorJOHN VICTORHEYMACHJOHN VICTOR HEYMACH9280HEYMACH, JOHN VICTORProfessor8.791890.00664145422research areas11.78550.0326845156coauthor of364.94852.768960similar to11222selected publicationsJAFFER AAJANIJAFFER A AJANI8473AJANI, JAFFER AProfessorWAYNE LHOFSTETTERWAYNE L HOFSTETTER9205HOFSTETTER, WAYNE LProfessorSTEPHEN GSWISHERSTEPHEN G SWISHER8671SWISHER, STEPHEN GProfessorDAVID CRICEDAVID C RICE8943RICE, DAVID CProfessorIGNACIO IVANWISTUBAIGNACIO IVAN WISTUBA9098WISTUBA, IGNACIO IVANProfessorAuthorship 2203963Authorship 232459312122072Gemma C, Mesches MH, Sepesi B, Choo K, Holmes DB, Bickford PCThe Journal of neuroscience : the official journal of the Society for NeuroscienceDiets enriched in foods with high antioxidant activity reverse age-induced decreases in cerebellar beta-adrenergic function and increases in proinflammatory cytokines. J Neurosci. 2002 Jul 15; 22(14):6114-20.J Neurosci2002-07-15T00:00:002002Diets enriched in foods with high antioxidant activity reverse age-induced decreases in cerebellar beta-adrenergic function and increases in proinflammatory cytokines.23143640Wilshire CL, Salvador R, Sepesi B, Niebisch S, Watson TJ, Litle VR, Peyre CG, Jones CE, Peters JHJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary TractReflux-associated oxygen desaturations: usefulness in diagnosing reflux-related respiratory symptoms. J Gastrointest Surg. 2013 Jan; 17(1):30-8.J Gastrointest Surg2012-11-10T00:00:002012Reflux-associated oxygen desaturations: usefulness in diagnosing reflux-related respiratory symptoms.Authorship 2529053Authorship 2538531Authorship 2546702Authorship 2546893Authorship 2587431Authorship 2598801Authorship 260808119957207Polomsky M, Jones CE, Sepesi B, O'Connor M, Matousek A, Hu R, Raymond DP, Litle VR, Watson TJ, Peters JHJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary TractShould elective repair of intrathoracic stomach be encouraged? J Gastrointest Surg. 2010 Feb; 14(2):203-10.J Gastrointest Surg2009-12-03T00:00:002009Should elective repair of intrathoracic stomach be encouraged?20033732Polomsky M, Hu R, Sepesi B, O'Connor M, Qui X, Raymond DP, Litle VR, Jones CE, Watson TJ, Peters JHSurgical endoscopyA population-based analysis of emergent vs. elective hospital admissions for an intrathoracic stomach. Surg Endosc. 2010 Jun; 24(6):1250-5.Surg Endosc2009-12-24T00:00:002009A population-based analysis of emergent vs. elective hospital admissions for an intrathoracic stomach.20473156Sepesi B, Raymond DP, Peters JHCurrent opinion in gastroenterologyEsophageal perforation: surgical, endoscopic and medical management strategies. Curr Opin Gastroenterol. 2010 Jul; 26(4):379-83.Curr Opin Gastroenterol2010-07-01T00:00:002010Esophageal perforation: surgical, endoscopic and medical management strategies.20980174Dubecz A, Sepesi B, Salvador R, Polomsky M, Watson TJ, Raymond DP, Jones CE, Litle VR, Wisnivesky JP, Peters JHJournal of the American College of SurgeonsSurgical resection for locoregional esophageal cancer is underutilized in the United States. J Am Coll Surg. 2010 Dec; 211(6):754-61.J Am Coll Surg2010-10-25T00:00:002010Surgical resection for locoregional esophageal cancer is underutilized in the United States.22015618Sepesi B, Moalem J, Galka E, Salzman P, Schoeniger LOJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary TractThe influence of staple size on fistula formation following distal pancreatectomy. J Gastrointest Surg. 2012 Feb; 16(2):267-74.J Gastrointest Surg2011-10-21T00:00:002011The influence of staple size on fistula formation following distal pancreatectomy.22939861Sepesi B, Swisher SG, Walsh GL, Correa A, Mehran RJ, Rice D, Roth J, Vaporciyan A, Hofstetter WLThe Journal of thoracic and cardiovascular surgeryOmental reinforcement of the thoracic esophagogastric anastomosis: an analysis of leak and reintervention rates in patients undergoing planned and salvage esophagectomy. J Thorac Cardiovasc Surg. 2012 Nov; 144(5):1146-50.J Thorac Cardiovasc Surg2012-08-28T00:00:002012Omental reinforcement of the thoracic esophagogastric anastomosis: an analysis of leak and reintervention rates in patients undergoing planned and salvage esophagectomy.24022442Francis AM, Sepesi B, Correa AM, Blum MA, Erasmus JJ, Lee JH, Maru DM, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Welsh JW, Swisher SG, Hofstetter WL, University of Texas MD Anderson Esophageal Cancer GroupAnnals of surgeryThe influence of histopathologic tumor viability on long-term survival and recurrence rates following neoadjuvant therapy for esophageal adenocarcinoma. Ann Surg. 2013 Sep; 258(3):500-7.Ann Surg2013-09-01T00:00:002013The influence of histopathologic tumor viability on long-term survival and recurrence rates following neoadjuvant therapy for esophageal adenocarcinoma.Authorship 2690171Authorship 269027119795177Sepesi B, Raymond DP, Polomsky M, Watson TJ, Litle VR, Jones CE, Hu R, Qiu X, Peters JHJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary TractDoes the value of PET-CT extend beyond pretreatment staging? An analysis of survival in surgical patients with esophageal cancer. J Gastrointest Surg. 2009 Dec; 13(12):2121-7.J Gastrointest Surg2009-10-01T00:00:002009Does the value of PET-CT extend beyond pretreatment staging? An analysis of survival in surgical patients with esophageal cancer.20347733Sepesi B, Watson TJ, Zhou D, Polomsky M, Litle VR, Jones CE, Raymond DP, Hu R, Qiu X, Peters JHJournal of the American College of SurgeonsAre endoscopic therapies appropriate for superficial submucosal esophageal adenocarcinoma? An analysis of esophagectomy specimens. J Am Coll Surg. 2010 Apr; 210(4):418-27.J Am Coll Surg2010-04-01T00:00:002010Are endoscopic therapies appropriate for superficial submucosal esophageal adenocarcinoma? An analysis of esophagectomy specimens.Authorship 274071220803613Gaur P, Sepesi B, Hofstetter WL, Correa AM, Bhutani MS, Watson TJ, Swisher SG, M. D. Anderson Esophageal Cancer Group, University of Rochester School of Medicine and Dentistry Foregut GroupCancerEndoscopic esophageal tumor length: a prognostic factor for patients with esophageal cancer. Cancer. 2011 Jan 01; 117(1):63-9.Cancer2010-08-27T00:00:002010Endoscopic esophageal tumor length: a prognostic factor for patients with esophageal cancer.Authorship 2917481Authorship 29248623Authorship 2980262Authorship 298835525239273Sepesi B, Walsh GLSeminars in diagnostic pathologySurgical therapy of ground-glass opacities. Semin Diagn Pathol. 2014 Jul; 31(4):289-92.Semin Diagn Pathol2014-06-12T00:00:002014Surgical therapy of ground-glass opacities.25444907Hao C, Wang L, Peng S, Cao M, Li H, Hu J, Huang X, Liu W, Zhang H, Wu S, Pataer A, Heymach JV, Eterovic AK, Zhang Q, Shaw KR, Chen K, Futreal A, Wang M, Hofstetter W, Mehran R, Rice D, Roth JA, Sepesi B, Swisher SG, Vaporciyan A, Walsh GL, Johnson FM, Fang BCancer lettersGene mutations in primary tumors and corresponding patient-derived xenografts derived from non-small cell lung cancer. Cancer Lett. 2015 Feb 01; 357(1):179-185.Cancer Lett2014-11-18T00:00:002014Gene mutations in primary tumors and corresponding patient-derived xenografts derived from non-small cell lung cancer.26279367Antonoff MB, Hofstetter WL, Correa AM, Bell JM, Sepesi B, Rice DC, Vaporciyan AA, Walsh GL, Mehran RJ, Swisher SG, Meyers BFThe Annals of thoracic surgeryClinical Prediction of Pathologic Complete Response in Superior Sulcus Non-Small Cell Lung Cancer. Ann Thorac Surg. 2016 Jan; 101(1):211-7.Ann Thorac Surg2015-08-14T00:00:002015Clinical Prediction of Pathologic Complete Response in Superior Sulcus Non-Small Cell Lung Cancer.26370343Rice D, Sepesi B, Heymach J, Swisher S, Vaporciyan AThe Lancet. OncologySABR vs surgery for NSCLC in the media. Lancet Oncol. 2015 Sep; 16(9):e422.Lancet Oncol2015-09-01T00:00:002015SABR vs surgery for NSCLC in the media.74Professor10Assistant ProfessorMARA BANTONOFFMARA B ANTONOFF11880ANTONOFF, MARA BAssistant ProfessorAuthorship 843057Authorship 844129Authorship 846481Authorship 847963Authorship 852603Authorship 853368Authorship 860413Authorship 862947Authorship 867724Annals of Thoracic SurgeryResults of Postdischarge Nursing Telephone Assessments. Annals of Thoracic Surgery. Results of Postdischarge Nursing Telephone AssessmentsJournal of Thoracic DiseaseStage I lung cancer-to operate or to radiate? That is the question. Journal of Thoracic Disease. 8:2324-2327.Stage I lung cancer-to operate or to radiate? That is the questionJournal of Cardiothoracic and Vascular AnesthesiaJournal of Cardiothoracic and Vascular Anesthesia. 30:930-935.Journal of Cardiothoracic and Vascular AnesthesiaJournal of Thoracic and Cardiovascular SurgeryOmental reinforcement of the thoracic esophagogastric anastomosis. Journal of Thoracic and Cardiovascular Surgery. Omental reinforcement of the thoracic esophagogastric anastomosisSurgical approach. 63-74.Surgical approachAnnals of Thoracic SurgeryThe Influence of Reconstructive Technique on Perioperative Pulmonary and Infectious Outcomes Following Chest Wall Resection. Annals of Thoracic Surgery. 102:1653-1659.The Influence of Reconstructive Technique on Perioperative Pulmonary and Infectious Outcomes Following Chest Wall ResectionThe Lancet OncologyLocal consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy. The Lancet Oncology. 17:1672-1682.Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapyClinical Cancer ResearchImage analysis-based assessment of PD-L1 and tumor-associated immune cells density supports distinct intratumoral microenvironment groups in non-small cell lung carcinoma patients. Clinical Cancer Research. 22:6278-6289.Image analysis-based assessment of PD-L1 and tumor-associated immune cells density supports distinct intratumoral microenvironment groups in non-small cell lung carcinoma patientsAnnals of SurgeryImpact of a fast-track esophagectomy protocol on esophageal cancer patient outcomes and hospital charges. Annals of Surgery. 261:1114-1123.Impact of a fast-track esophagectomy protocol on esophageal cancer patient outcomes and hospital charges29178133Wang JF, Pu X, Zhang X, Chen K, Xi Y, Wang J, Mao X, Zhang J, Heymach JV, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Meng QH, Shaw KR, Eterovic AK, Fang BCancerVariants with a low allele frequency detected in genomic DNA affect the accuracy of mutation detection in cell-free DNA by next-generation sequencing. Cancer. 2018 03 01; 124(5):1061-1069.Cancer2017-11-27T00:00:002017Variants with a low allele frequency detected in genomic DNA affect the accuracy of mutation detection in cell-free DNA by next-generation sequencing.D008654Disorders1775400.668789MesotheliomaAuthorship 88951515D002289Disorders64653060.283287Carcinoma, Non-Small-Cell LungD008175Disorders1353114820.198988Lung NeoplasmsD016629Procedures1198860.699616EsophagectomyAuthorship 9050445Authorship 9054153Authorship 9065852Authorship 90936310Authorship 90953612Authorship 9097961Authorship 9112451Authorship 91202618Authorship 9133116Authorship 9145627Authorship 91468827Authorship 9149871Authorship 91521215Authorship 9152296Authorship 9158837Authorship 9159659Authorship 91616313Authorship 91708412Authorship 91995614Authorship 9201495Authorship 92071018Authorship 92134410Authorship 9215203Authorship 9218883Authorship 9229025Authorship 9229453Authorship 9230081Authorship 92328727Authorship 9234091Authorship 92351615Authorship 9239434Authorship 92431210Authorship 9243541Authorship 9256531Authorship 9256648Authorship 9268607Authorship 9275613Authorship 9280931Authorship 9281137Authorship 92813510Authorship 9285817Authorship 9300064Authorship 9302278Authorship 9322766Authorship 93342033Authorship 93533620Authorship 9362693Authorship 9363466Authorship 9380751426680311Sepesi B, Schmidt HE, Lada M, Correa AM, Walsh GL, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Ajani JA, Watson TJ, Swisher SG, Low DE, Hofstetter WLThe Annals of thoracic surgerySurvival in Patients With Esophageal Adenocarcinoma Undergoing Trimodality Therapy Is Independent of Regional Lymph Node Location. Ann Thorac Surg. 2016 Mar; 101(3):1075-80; Discussion 1080-1.Ann Thorac Surg2015-12-08T00:00:002015Survival in Patients With Esophageal Adenocarcinoma Undergoing Trimodality Therapy Is Independent of Regional Lymph Node Location.26731586Hassid VJ, Sepesi BPlastic and reconstructive surgeryChronic Osteomyelitis of the Manubrio-Clavicular Joint following Breast Augmentation. Plast Reconstr Surg. 2016 Feb; 137(2):493e-494e.Plast Reconstr Surg2016-02-01T00:00:002016Chronic Osteomyelitis of the Manubrio-Clavicular Joint following Breast Augmentation.27083250Antonoff MB, Ragalie W, Correa AM, Spicer JD, Sepesi B, Roth JA, Walsh GL, Hofstetter WL, Swisher SG, Rice DC, Vaporciyan AA, Mehran RJThe Annals of thoracic surgeryResults of Postdischarge Nursing Telephone Assessments: Persistent Symptoms Common Among Pulmonary Resection Patients. Ann Thorac Surg. 2016 Jul; 102(1):276-81.Ann Thorac Surg2016-04-12T00:00:002016Results of Postdischarge Nursing Telephone Assessments: Persistent Symptoms Common Among Pulmonary Resection Patients.27521965Cata JP, Jones J, Sepesi B, Mehran RJ, Rodriguez-Restrepo A, Lasala J, Feng L, Gottumukkala VJournal of cardiothoracic and vascular anesthesiaLack of Association Between Dexamethasone and Long-Term Survival After Non-Small Cell Lung Cancer Surgery. J Cardiothorac Vasc Anesth. 2016 Aug; 30(4):930-5.J Cardiothorac Vasc Anesth2016-01-08T00:00:002016Lack of Association Between Dexamethasone and Long-Term Survival After Non-Small Cell Lung Cancer Surgery.27526650Spicer JD, Shewale JB, Antonoff MB, Correa AM, Hofstetter WB, Rice DC, Vaporciyan AA, Mehran RJ, Walsh GL, Roth JA, Swisher SG, Sepesi BThe Annals of thoracic surgeryThe Influence of Reconstructive Technique on Perioperative Pulmonary and Infectious Outcomes Following Chest Wall Resection. Ann Thorac Surg. 2016 Nov; 102(5):1653-1659.Ann Thorac Surg2016-08-12T00:00:002016The Influence of Reconstructive Technique on Perioperative Pulmonary and Infectious Outcomes Following Chest Wall Resection.27252415Parra ER, Behrens C, Rodriguez-Canales J, Lin H, Mino B, Blando J, Zhang J, Gibbons DL, Heymach JV, Sepesi B, Swisher SG, Weissferdt A, Kalhor N, Izzo J, Kadara H, Moran C, Lee JJ, Wistuba IIClinical cancer research : an official journal of the American Association for Cancer ResearchImage Analysis-based Assessment of PD-L1 and Tumor-Associated Immune Cells Density Supports Distinct Intratumoral Microenvironment Groups in Non-small Cell Lung Carcinoma Patients. Clin Cancer Res. 2016 Dec 15; 22(24):6278-6289.Clin Cancer Res2016-06-01T00:00:002016Image Analysis-based Assessment of PD-L1 and Tumor-Associated Immune Cells Density Supports Distinct Intratumoral Microenvironment Groups in Non-small Cell Lung Carcinoma Patients.27746966Sepesi B, Rice DC, Heymach JV, Vaporciyan AA, Swisher SGJournal of thoracic diseaseStage I lung cancer-to operate or to radiate? that is the question. J Thorac Dis. 2016 Sep; 8(9):2324-2327.J Thorac Dis2016-09-01T00:00:002016Stage I lung cancer-to operate or to radiate? that is the question.27789196Gomez DR, Blumenschein GR, Lee JJ, Hernandez M, Ye R, Camidge DR, Doebele RC, Skoulidis F, Gaspar LE, Gibbons DL, Karam JA, Kavanagh BD, Tang C, Komaki R, Louie AV, Palma DA, Tsao AS, Sepesi B, William WN, Zhang J, Shi Q, Wang XS, Swisher SG, Heymach JVThe Lancet. OncologyLocal consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study. Lancet Oncol. 2016 Dec; 17(12):1672-1682.Lancet Oncol2016-10-24T00:00:002016Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study.28154950Pezzi TA, Mohamed AS, Fuller CD, Blanchard P, Pezzi C, Sepesi B, Hahn SM, Gomez DR, Chun SGAnnals of surgical oncologyRadiation Therapy is Independently Associated with Worse Survival After R0-Resection for Stage I-II Non-small Cell Lung Cancer: An Analysis of the National Cancer Data Base. Ann Surg Oncol. 2017 May; 24(5):1419-1427.Ann Surg Oncol2017-02-02T00:00:002017Radiation Therapy is Independently Associated with Worse Survival After R0-Resection for Stage I-II Non-small Cell Lung Cancer: An Analysis of the National Cancer Data Base.28495066Antonoff MB, Correa AM, Sepesi B, Nguyen QN, Walsh GL, Swisher SG, Vaporciyan AA, Mehran RJ, Hofstetter WL, Rice DCThe Journal of thoracic and cardiovascular surgerySalvage pulmonary resection after stereotactic body radiotherapy: A feasible and safe option for local failure in selected patients. J Thorac Cardiovasc Surg. 2017 08; 154(2):689-699.J Thorac Cardiovasc Surg2017-04-14T00:00:002017Salvage pulmonary resection after stereotactic body radiotherapy: A feasible and safe option for local failure in selected patients.28552766Sepesi B, Gold KA, Correa AM, Heymach JV, Vaporciyan AA, Roszik J, Dmitrovsky E, Liu XJournal of thoracic oncology : official publication of the International Association for the Study of Lung CancerThe Influence of Body Mass Index on Overall Survival?Following Surgical Resection of Non-Small Cell Lung Cancer. J Thorac Oncol. 2017 08; 12(8):1280-1287.J Thorac Oncol2017-05-25T00:00:002017The Influence of Body Mass Index on Overall Survival?Following Surgical Resection of Non-Small Cell Lung Cancer.28363370Sepesi BThoracic surgery clinicsManagement of Breast Cancer Invading Chest Wall. Thorac Surg Clin. 2017 May; 27(2):159-163.Thorac Surg Clin2017-03-02T00:00:002017Management of Breast Cancer Invading Chest Wall.28366460Bassuner JK, Rice DC, Antonoff MB, Correa AM, Walsh GL, Vaporciyan AA, Garg N, Sepesi B, Swisher SG, Hofstetter WL, Roth JA, Mehran RJThe Annals of thoracic surgeryPolytetrafluoroethylene or Acellular Dermal Matrix for Diaphragmatic Reconstruction? Ann Thorac Surg. 2017 Jun; 103(6):1710-1714.Ann Thorac Surg2017-03-31T00:00:002017Polytetrafluoroethylene or Acellular Dermal Matrix for Diaphragmatic Reconstruction?28254787Peters HL, Tripathi SC, Kerros C, Katayama H, Garber HR, St John LS, Federico L, Meraz IM, Roth JA, Sepesi B, Majidi M, Ruisaard K, Clise-Dwyer K, Roszik J, Gibbons DL, Heymach JV, Swisher SG, Bernatchez C, Alatrash G, Hanash S, Molldrem JJCancer immunology researchSerine Proteases Enhance Immunogenic Antigen Presentation on Lung Cancer Cells. Cancer Immunol Res. 2017 04; 5(4):319-329.Cancer Immunol Res2017-03-02T00:00:002017Serine Proteases Enhance Immunogenic Antigen Presentation on Lung Cancer Cells.28259750Sun B, Brooks ED, Komaki R, Liao Z, Jeter M, McAleer M, Balter PA, Welsh JD, O'Reilly M, Gomez D, Hahn SM, Sepesi B, Rice DC, Heymach JV, Chang JYJournal of thoracic oncology : official publication of the International Association for the Study of Lung CancerLong-Term Outcomes of Salvage Stereotactic Ablative?Radiotherapy for Isolated Lung Recurrence of Non-Small Cell Lung Cancer: A Phase II Clinical Trial. J Thorac Oncol. 2017 06; 12(6):983-992.J Thorac Oncol2017-03-01T00:00:002017Long-Term Outcomes of Salvage Stereotactic Ablative?Radiotherapy for Isolated Lung Recurrence of Non-Small Cell Lung Cancer: A Phase II Clinical Trial.28343305Salem A, Bell D, Sepesi B, Papadimitrakopoulou V, El-Naggar A, Moran CA, Kalhor NVirchows Archiv : an international journal of pathologyClinicopathologic and genetic features of primary bronchopulmonary mucoepidermoid carcinoma: the MD Anderson Cancer Center experience and comprehensive review of the literature. Virchows Arch. 2017 Jun; 470(6):619-626.Virchows Arch2017-03-25T00:00:002017Clinicopathologic and genetic features of primary bronchopulmonary mucoepidermoid carcinoma: the MD Anderson Cancer Center experience and comprehensive review of the literature.28523177Lasala JD, Tsai J, Rodriguez-Restrepo A, Atay SM, Sepesi BJournal of thoracic diseaseSystolic anterior motion of the mitral valve-the mechanism of postural hypotension following left intrapericardial pneumonectomy. J Thorac Dis. 2017 Apr; 9(4):E354-E357.J Thorac Dis2017-04-01T00:00:002017Systolic anterior motion of the mitral valve-the mechanism of postural hypotension following left intrapericardial pneumonectomy.28733428Reuben A, Gittelman R, Gao J, Zhang J, Yusko EC, Wu CJ, Emerson R, Zhang J, Tipton C, Li J, Quek K, Gopalakrishnan V, Chen R, Vence LM, Cascone T, Vignali M, Fujimoto J, Rodriguez-Canales J, Parra ER, Little LD, Gumbs C, Forget MA, Federico L, Haymaker C, Behrens C, Benzeno S, Bernatchez C, Sepesi B, Gibbons DL, Wargo JA, William WN, Swisher S, Heymach JV, Robins H, Lee JJ, Sharma P, Allison JP, Futreal PA, Wistuba II, Zhang JCancer discoveryTCR Repertoire Intratumor Heterogeneity in Localized Lung Adenocarcinomas: An Association with Predicted Neoantigen Heterogeneity and Postsurgical Recurrence. Cancer Discov. 2017 10; 7(10):1088-1097.Cancer Discov2017-07-21T00:00:002017TCR Repertoire Intratumor Heterogeneity in Localized Lung Adenocarcinomas: An Association with Predicted Neoantigen Heterogeneity and Postsurgical Recurrence.28987393Atay SM, Correa AM, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh G, Antonoff MBThe Annals of thoracic surgeryPerioperative Outcomes of Patients Undergoing Lobectomy on Clopidogrel. Ann Thorac Surg. 2017 Dec; 104(6):1821-1828.Ann Thorac Surg2017-10-05T00:00:002017Perioperative Outcomes of Patients Undergoing Lobectomy on Clopidogrel.28838719Sepesi B, Correa AM, Dmitrovsky E, Liu XJournal of thoracic oncology : official publication of the International Association for the Study of Lung CancerReply to "Influence of Body Mass Index on Overall Survival Following Surgical Resection of Non-Small Cell Lung Cancer: Methodological Issues". J Thorac Oncol. 2017 09; 12(9):e150-e151.J Thorac Oncol2017-09-01T00:00:002017Reply to "Influence of Body Mass Index on Overall Survival Following Surgical Resection of Non-Small Cell Lung Cancer: Methodological Issues".28851660Weissferdt A, Kalhor N, Bishop JA, Jang SJ, Ro J, Petersson F, Wu B, Langman G, Bancroft H, Bi Y, Meng Y, Medeiros F, Brunnstrom H, Spagnolo D, Chai SM, Laycock A, Wakely PE, Elmberger G, Soares FA, Campos AH, Gumurdulu D, Alvarado-Cabrero I, Coppola D, Correa AM, Rice D, Mehran RJ, Sepesi B, Walsh G, Kaiser L, Moran CAHuman pathologyThymoma: a clinicopathological correlation of 1470 cases. Hum Pathol. 2018 03; 73:7-15.Hum Pathol2017-08-26T00:00:002017Thymoma: a clinicopathological correlation of 1470 cases.29034208Bloom BC, Augustyn A, Sepesi B, Patel S, Shah SJ, Komaki RU, Schild SE, Chun SGFrontiers in oncologyProphylactic Cranial Irradiation Following Surgical Resection of Early-Stage Small-Cell Lung Cancer: A Review of the Literature. Front Oncol. 2017; 7:228.Front Oncol2017-09-29T00:00:002017Prophylactic Cranial Irradiation Following Surgical Resection of Early-Stage Small-Cell Lung Cancer: A Review of the Literature.28817374Nelson DB, Rice DC, Niu J, Atay S, Vaporciyan AA, Antonoff M, Hofstetter WL, Walsh GL, Swisher SG, Roth JA, Tsao A, Gomez D, Giordano SH, Mehran R, Sepesi BJournal of clinical oncology : official journal of the American Society of Clinical OncologyLong-Term Survival Outcomes of Cancer-Directed Surgery for Malignant Pleural Mesothelioma: Propensity Score Matching Analysis. J Clin Oncol. 2017 Oct 10; 35(29):3354-3362.J Clin Oncol2017-08-17T00:00:002017Long-Term Survival Outcomes of Cancer-Directed Surgery for Malignant Pleural Mesothelioma: Propensity Score Matching Analysis.28885712Blum Murphy M, Xiao L, Patel VR, Maru DM, Correa AM, G Amlashi F, Liao Z, Komaki R, Lin SH, Skinner HD, Vaporciyan A, Walsh GL, Swisher SG, Sepesi B, Lee JH, Bhutani MS, Weston B, Hofstetter WL, Ajani JACancerPathological complete response in patients with esophageal cancer after the trimodality approach: The association with baseline variables and survival-The University of Texas MD Anderson Cancer Center experience. Cancer. 2017 Nov 01; 123(21):4106-4113.Cancer2017-09-08T00:00:002017Pathological complete response in patients with esophageal cancer after the trimodality approach: The association with baseline variables and survival-The University of Texas MD Anderson Cancer Center experience.29195578Sepesi B, Cuentas EP, Canales JR, Behrens C, Correa AM, Vaporciyan A, Weissferdt A, Kalhor N, Moran C, Swisher S, Wistuba ISeminars in thoracic and cardiovascular surgeryProgrammed Death Cell Ligand 1 (PD-L1) Is Associated With Survival in Stage I Non-Small Cell Lung Cancer. Semin Thorac Cardiovasc Surg. 2017 Autumn; 29(3):408-415.Semin Thorac Cardiovasc Surg2017-05-26T00:00:002017Programmed Death Cell Ligand 1 (PD-L1) Is Associated With Survival in Stage I Non-Small Cell Lung Cancer.29246722Yu W, Tang C, Hobbs BP, Li X, Koay EJ, Wistuba II, Sepesi B, Behrens C, Rodriguez Canales J, Parra Cuentas ER, Erasmus JJ, Court LE, Chang JYInternational journal of radiation oncology, biology, physicsDevelopment and Validation of a Predictive Radiomics Model for Clinical Outcomes in Stage I Non-small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2018 11 15; 102(4):1090-1097.Int J Radiat Oncol Biol Phys2017-11-15T00:00:002017Development and Validation of a Predictive Radiomics Model for Clinical Outcomes in Stage I Non-small Cell Lung Cancer.29268359Atay SM, Blum M, Sepesi BJournal of thoracic diseaseAdjuvant chemotherapy following trimodality therapy for esophageal carcinoma-Is the evidence sufficient? J Thorac Dis. 2017 Oct; 9(10):3626-3629.J Thorac Dis2017-10-01T00:00:002017Adjuvant chemotherapy following trimodality therapy for esophageal carcinoma-Is the evidence sufficient?29331175Negrao MV, Quek K, Zhang J, Sepesi BThe Journal of thoracic and cardiovascular surgeryTRACERx: Tracking tumor evolution to impact the course of lung cancer. J Thorac Cardiovasc Surg. 2018 03; 155(3):1199-1202.J Thorac Cardiovasc Surg2017-11-16T00:00:002017TRACERx: Tracking tumor evolution to impact the course of lung cancer.29548588Sepesi B, Ye Y, Mitchell KG, Zhang L, Gu J, Ji L, Antonoff MB, Hofstetter WL, Rice DC, Mehran RJ, Walsh GL, Vaporciyan AA, Swisher SG, Roth JA, Wu XThe Journal of thoracic and cardiovascular surgeryGenetic variants in cytokine signaling pathways and clinical outcomes in early-stage lung cancer patients. J Thorac Cardiovasc Surg. 2018 06; 155(6):2635-2645.e15.J Thorac Cardiovasc Surg2018-02-15T00:00:002018Genetic variants in cytokine signaling pathways and clinical outcomes in early-stage lung cancer patients.29302695Pezzi TA, Schwartz DL, Mohamed ASR, Welsh JW, Komaki RU, Hahn SM, Sepesi B, Pezzi CM, Fuller CD, Chun SGJAMA oncologyBarriers to Combined-Modality Therapy for Limited-Stage Small Cell Lung Cancer. JAMA Oncol. 2018 08 01; 4(8):e174504.JAMA Oncol2018-08-01T00:00:002018Barriers to Combined-Modality Therapy for Limited-Stage Small Cell Lung Cancer.29303625Nelson DB, Rice DC, Niu J, Mehran RJ, Sepesi BJournal of clinical oncology : official journal of the American Society of Clinical OncologyReply to S.E. Vogl. J Clin Oncol. 2018 02 20; 36(6):625-626.J Clin Oncol2018-01-05T00:00:002018Reply to S.E. Vogl.29386574Tang C, Hobbs B, Amer A, Li X, Behrens C, Canales JR, Cuentas EP, Villalobos P, Fried D, Chang JY, Hong DS, Welsh JW, Sepesi B, Court L, Wistuba II, Koay EJScientific reportsDevelopment of an Immune-Pathology Informed Radiomics Model for Non-Small Cell Lung Cancer. Sci Rep. 2018 01 31; 8(1):1922.Sci Rep2018-01-31T00:00:002018Development of an Immune-Pathology Informed Radiomics Model for Non-Small Cell Lung Cancer.29526824Parra ER, Villalobos P, Zhang J, Behrens C, Mino B, Swisher S, Sepesi B, Weissferdt A, Kalhor N, Heymach JV, Moran C, Zhang J, Lee J, Rodriguez-Canales J, Gibbons D, Wistuba IIJournal of thoracic oncology : official publication of the International Association for the Study of Lung CancerImmunohistochemical and Image Analysis-Based Study Shows That Several Immune Checkpoints are Co-expressed in Non-Small Cell Lung Carcinoma Tumors. J Thorac Oncol. 2018 06; 13(6):779-791.J Thorac Oncol2018-03-08T00:00:002018Immunohistochemical and Image Analysis-Based Study Shows That Several Immune Checkpoints are Co-expressed in Non-Small Cell Lung Carcinoma Tumors.29530770Van Haren RM, Mehran RJ, Mena GE, Correa AM, Antonoff MB, Baker CM, Woodard TC, Hofstetter WL, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Rice DCThe Annals of thoracic surgeryEnhanced Recovery Decreases Pulmonary and Cardiac Complications After Thoracotomy for Lung Cancer. Ann Thorac Surg. 2018 07; 106(1):272-279.Ann Thorac Surg2018-03-09T00:00:002018Enhanced Recovery Decreases Pulmonary and Cardiac Complications After Thoracotomy for Lung Cancer.29534957Nelson DB, Godoy MCB, Benveniste MF, Shewale JB, Spicer JD, Mitchell KG, Hofstetter WL, Mehran RJ, Rice DC, Sepesi B, Walsh GL, Vaporciyan AA, Swisher SG, Roth JA, Antonoff MBThe Annals of thoracic surgeryClinicoradiographic Predictors of Aggressive Biology in Lung Cancer With Ground Glass Components. Ann Thorac Surg. 2018 07; 106(1):235-241.Ann Thorac Surg2018-03-11T00:00:002018Clinicoradiographic Predictors of Aggressive Biology in Lung Cancer With Ground Glass Components.29605441Nelson DB, Dhupar R, Katkhuda R, Correa A, Goltsov A, Maru D, Sepesi B, Antonoff MB, Mehran RJ, Rice DC, Vaporciyan AA, Davila M, Davila R, Betancourt S, Ajani J, Hofstetter WLThe Journal of thoracic and cardiovascular surgeryOutcomes after endoscopic mucosal resection or esophagectomy for submucosal esophageal adenocarcinoma. J Thorac Cardiovasc Surg. 2018 07; 156(1):406-413.e3.J Thorac Cardiovasc Surg2018-03-12T00:00:002018Outcomes after endoscopic mucosal resection or esophagectomy for submucosal esophageal adenocarcinoma.29432718Shewale JB, Nelson DB, Rice DC, Sepesi B, Hofstetter WL, Mehran RJ, Vaporciyan AA, Walsh GL, Swisher SG, Roth JA, Antonoff MBThe Annals of thoracic surgeryNatural History of Ground-Glass Lesions Among Patients With Previous Lung Cancer. Ann Thorac Surg. 2018 06; 105(6):1671-1677.Ann Thorac Surg2018-02-09T00:00:002018Natural History of Ground-Glass Lesions Among Patients With Previous Lung Cancer.29510096Sepesi B, Nelson DB, Mitchell KG, Gibbons DL, Heymach JV, Vaporciyan AA, Swisher SG, Roszik JThe Annals of thoracic surgeryPrognostic Value of PD-L1 mRNA Sequencing Expression Profile in Non-Small Cell Lung Cancer. Ann Thorac Surg. 2018 06; 105(6):1621-1626.Ann Thorac Surg2018-03-03T00:00:002018Prognostic Value of PD-L1 mRNA Sequencing Expression Profile in Non-Small Cell Lung Cancer.29211849Nelson DB, Rice DC, Niu J, Atay SM, Vaporciyan AA, Antonoff MB, Hofstetter WL, Walsh GL, Swisher SG, Roth JA, Tsao AS, Gomez DR, Giordano SH, Mehran RJ, Sepesi BEuropean journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic SurgeryPredictors of trimodality therapy and trends in therapy for malignant pleural mesothelioma. Eur J Cardiothorac Surg. 2018 05 01; 53(5):960-966.Eur J Cardiothorac Surg2018-05-01T00:00:002018Predictors of trimodality therapy and trends in therapy for malignant pleural mesothelioma.29217088Cascone T, Gold KA, Swisher SG, Liu DD, Fossella FV, Sepesi B, Pataer A, Weissferdt A, Kalhor N, Vaporciyan AA, Hofstetter WL, Wistuba II, Heymach JV, Kim ES, William WNThe Annals of thoracic surgeryInduction Cisplatin Docetaxel Followed by Surgery and Erlotinib in Non-Small Cell Lung Cancer. Ann Thorac Surg. 2018 Feb; 105(2):418-424.Ann Thorac Surg2017-12-06T00:00:002017Induction Cisplatin Docetaxel Followed by Surgery and Erlotinib in Non-Small Cell Lung Cancer.29339375Meraz IM, Majidi M, Cao X, Lin H, Li L, Wang J, Baladandayuthapani V, Rice D, Sepesi B, Ji L, Roth JACancer immunology researchTUSC2 Immunogene Therapy Synergizes with Anti-PD-1 through Enhanced Proliferation and Infiltration of Natural Killer Cells in Syngeneic Kras-Mutant Mouse Lung Cancer Models. Cancer Immunol Res. 2018 02; 6(2):163-177.Cancer Immunol Res2018-01-16T00:00:002018TUSC2 Immunogene Therapy Synergizes with Anti-PD-1 through Enhanced Proliferation and Infiltration of Natural Killer Cells in Syngeneic Kras-Mutant Mouse Lung Cancer Models.30012210Brahmer JR, Govindan R, Anders RA, Antonia SJ, Sagorsky S, Davies MJ, Dubinett SM, Ferris A, Gandhi L, Garon EB, Hellmann MD, Hirsch FR, Malik S, Neal JW, Papadimitrakopoulou VA, Rimm DL, Schwartz LH, Sepesi B, Yeap BY, Rizvi NA, Herbst RSJournal for immunotherapy of cancerThe Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC). J Immunother Cancer. 2018 07 17; 6(1):75.J Immunother Cancer2018-07-17T00:00:002018The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC).30118712Nelson DB, Lapid DJ, Mitchell KG, Correa AM, Hofstetter WL, Mehran RJ, Rice DC, Sepesi B, Walsh GL, Vaporciyan AA, Swisher SG, Roth JA, Antonoff MBThe Annals of thoracic surgeryPerioperative Outcomes for Stage I Non-Small Cell Lung Cancer: Differences Between Men and Women. Ann Thorac Surg. 2018 11; 106(5):1499-1503.Ann Thorac Surg2018-08-15T00:00:002018Perioperative Outcomes for Stage I Non-Small Cell Lung Cancer: Differences Between Men and Women.30266660Tsao AS, Lindwasser OW, Adjei AA, Adusumilli PS, Beyers ML, Blumenthal GM, Bueno R, Burt BM, Carbone M, Dahlberg SE, de Perrot M, Fennell DA, Friedberg J, Gill RR, Gomez DR, Harpole DH, Hassan R, Hesdorffer M, Hirsch FR, Hmeljak J, Kindler HL, Korn EL, Liu G, Mansfield AS, Nowak AK, Pass HI, Peikert T, Rimner A, Robinson BWS, Rosenzweig KE, Rusch VW, Salgia R, Sepesi B, Simone CB, Sridhara R, Szlosarek P, Taioli E, Tsao MS, Yang H, Zauderer MG, Malik SMJournal of thoracic oncology : official publication of the International Association for the Study of Lung CancerCurrent and Future Management of Malignant Mesothelioma: A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation. J Thorac Oncol. 2018 11; 13(11):1655-1667.J Thorac Oncol2018-09-25T00:00:002018Current and Future Management of Malignant Mesothelioma: A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation.30109699Shewale JB, Mitchell KG, Nelson DB, Conley AP, Rice DC, Antonoff MB, Hofstetter WL, Walsh GL, Swisher SG, Roth JA, Mehran RJ, Vaporciyan AA, Weissferdt A, Sepesi BJournal of surgical oncologyPredictors of survival after resection of primary sarcomas of the chest wall-A large, single-institution series. J Surg Oncol. 2018 Sep; 118(3):518-524.J Surg Oncol2018-08-15T00:00:002018Predictors of survival after resection of primary sarcomas of the chest wall-A large, single-institution series.29871672Parra ER, Villalobos P, Behrens C, Jiang M, Pataer A, Swisher SG, William WN, Zhang J, Lee J, Cascone T, Heymach JV, Forget MA, Haymaker C, Bernatchez C, Kalhor N, Weissferdt A, Moran C, Zhang J, Vaporciyan A, Gibbons DL, Sepesi B, Wistuba IIJournal for immunotherapy of cancerEffect of neoadjuvant chemotherapy on the immune microenvironment in non-small cell lung carcinomas as determined by multiplex immunofluorescence and image analysis approaches. J Immunother Cancer. 2018 06 06; 6(1):48.J Immunother Cancer2018-06-06T00:00:002018Effect of neoadjuvant chemotherapy on the immune microenvironment in non-small cell lung carcinomas as determined by multiplex immunofluorescence and image analysis approaches.30508527Nelson DB, Tam AL, Mitchell KG, Rice DC, Mehran RJ, Sepesi B, Antonoff MB, Vaporciyan AA, Hofstetter WLThe Annals of thoracic surgeryLocal Recurrence After Microwave Ablation of Lung Malignancies: A Systematic Review. Ann Thorac Surg. 2019 06; 107(6):1876-1883.Ann Thorac Surg2018-11-30T00:00:002018Local Recurrence After Microwave Ablation of Lung Malignancies: A Systematic Review.30635188Nelson DB, Tayob N, Mitchell KG, Correa AM, Hofstetter WL, Sepesi B, Walsh GL, Vaporciyan AA, Swisher SG, Antonoff MB, Roth JA, Rice DC, Vauthey JN, Mehran RJThe Journal of thoracic and cardiovascular surgerySurgical margins and risk of local recurrence after wedge resection of colorectal pulmonary metastases. J Thorac Cardiovasc Surg. 2019 04; 157(4):1648-1655.J Thorac Cardiovasc Surg2018-11-26T00:00:002018Surgical margins and risk of local recurrence after wedge resection of colorectal pulmonary metastases.30612991Van Haren RM, Correa AM, Sepesi B, Rice DC, Hofstetter WL, Mehran RJ, Vaporciyan AA, Walsh GL, Roth JA, Swisher SG, Antonoff MBThe Annals of thoracic surgeryGround Glass Lesions on Chest Imaging: Evaluation of Reported Incidence in Cancer Patients Using Natural Language Processing. Ann Thorac Surg. 2019 03; 107(3):936-940.Ann Thorac Surg2018-10-26T00:00:002018Ground Glass Lesions on Chest Imaging: Evaluation of Reported Incidence in Cancer Patients Using Natural Language Processing.D011013Procedures1808090.669454PneumonectomyAuthorship 941257230819811Casal RF, Sepesi B, Sagar AS, Tschirren J, Chen M, Li L, Sunny J, Williams J, Grosu HB, Eapen GA, Jimenez CA, Ost DEThe European respiratory journalCentrally located lung cancer and risk of?occult nodal disease: an objective evaluation of multiple definitions of tumour centrality with dedicated imaging software. Eur Respir J. 2019 05; 53(5).Eur Respir J2019-05-09T00:00:002019Centrally located lung cancer and risk of?occult nodal disease: an objective evaluation of multiple definitions of tumour centrality with dedicated imaging software.Authorship 943449830888418Nelson DB, Mitchell KG, Weston BR, Betancourt S, Maru D, Rice DC, Mehran RJ, Sepesi B, Antonoff MB, Walsh GL, Swisher SG, Roth JA, Vaporciyan AA, Blum M, Hofstetter WLDiseases of the esophagus : official journal of the International Society for Diseases of the EsophagusShould endoscopic mucosal resection be attempted for cT2N0 esophageal cancer? Dis Esophagus. 2019 Dec 13; 32(10):1-6.Dis Esophagus2019-12-13T00:00:002019Should endoscopic mucosal resection be attempted for cT2N0 esophageal cancer?Authorship 9442421030227129Spicer JD, Shewale JB, Nelson DB, Mitchell KG, Bott MJ, Valli?res E, Wilshire CL, Vaporciyan AA, Swisher SG, Jones DR, Darling GE, Sepesi BThe Annals of thoracic surgeryMultimodality Therapy for N2 Non-Small Cell Lung Cancer: An Evolving Paradigm. Ann Thorac Surg. 2019 01; 107(1):277-284.Ann Thorac Surg2018-09-15T00:00:002018Multimodality Therapy for N2 Non-Small Cell Lung Cancer: An Evolving Paradigm.Authorship 9443548Authorship 945099230962972Corsini EM, Sepesi BJournal of thoracic diseaseEditorial on "Complications after esophagectomy are associated with extremes of body mass index". J Thorac Dis. 2019 Feb; 11(2):354-356.J Thorac Dis2019-02-01T00:00:002019Editorial on "Complications after esophagectomy are associated with extremes of body mass index".30928553Mohammad Z, Mitchell KG, Nelson DB, Robb C, Jreissaty C, Tu J, Vaporciyan AA, Sepesi B, Antonoff MBThe Annals of thoracic surgeryLung Cancer Patient Perceptions of the Value of an Outreach Thoracic Surgical Clinic. Ann Thorac Surg. 2019 08; 108(2):358-362.Ann Thorac Surg2019-03-27T00:00:002019Lung Cancer Patient Perceptions of the Value of an Outreach Thoracic Surgical Clinic.Authorship 94580510Authorship 945856531014665Nelson DB, Mehran RJ, Mitchell KG, Correa AM, Sepesi B, Antonoff MB, Rice DCThe Journal of thoracic and cardiovascular surgeryEnhanced recovery after thoracic surgery is associated with improved adjuvant chemotherapy completion for non-small cell lung cancer. J Thorac Cardiovasc Surg. 2019 07; 158(1):279-286.e1.J Thorac Cardiovasc Surg2019-03-21T00:00:002019Enhanced recovery after thoracic surgery is associated with improved adjuvant chemotherapy completion for non-small cell lung cancer.31004583Nelson DB, Mehran RJ, Mitchell KG, Rajaram R, Correa AM, Bassett RL, Antonoff MB, Hofstetter WL, Roth JA, Sepesi B, Swisher SG, Walsh GL, Vaporciyan AA, Rice DCThe Annals of thoracic surgeryRobotic-Assisted Lobectomy for Non-Small Cell Lung Cancer: A Comprehensive Institutional Experience. Ann Thorac Surg. 2019 08; 108(2):370-376.Ann Thorac Surg2019-04-18T00:00:002019Robotic-Assisted Lobectomy for Non-Small Cell Lung Cancer: A Comprehensive Institutional Experience.Authorship 9468601931067138Gomez DR, Tang C, Zhang J, Blumenschein GR, Hernandez M, Lee JJ, Ye R, Palma DA, Louie AV, Camidge DR, Doebele RC, Skoulidis F, Gaspar LE, Welsh JW, Gibbons DL, Karam JA, Kavanagh BD, Tsao AS, Sepesi B, Swisher SG, Heymach JVJournal of clinical oncology : official journal of the American Society of Clinical OncologyLocal Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study. J Clin Oncol. 2019 06 20; 37(18):1558-1565.J Clin Oncol2019-05-08T00:00:002019Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study.Authorship 94723313Authorship 9478539Authorship 948012531102632Mitchell KG, Ikoma N, Nelson DB, Maru DM, Erasmus JJ, Weston BR, Vaporciyan AA, Antonoff MB, Mehran RJ, Rice DC, Roth JA, Swisher SG, Sepesi B, Walsh GL, Correa AM, Das P, Blum MA, Badgwell BD, Hofstetter WLThe Annals of thoracic surgeryMediastinal Nodal Involvement After Neoadjuvant Chemoradiation for Siewert II/III Adenocarcinoma. Ann Thorac Surg. 2019 09; 108(3):845-851.Ann Thorac Surg2019-05-15T00:00:002019Mediastinal Nodal Involvement After Neoadjuvant Chemoradiation for Siewert II/III Adenocarcinoma.31149979Nelson DB, Cata JP, Niu J, Mitchell KG, Vaporciyan AA, Antonoff MB, Hofstetter WL, Giordano SH, Sepesi B, Mehran RJ, Rice DCPainPersistent opioid use is associated with worse survival after lobectomy for stage I non-small cell lung cancer. Pain. 2019 10; 160(10):2365-2373.Pain2019-10-01T00:00:002019Persistent opioid use is associated with worse survival after lobectomy for stage I non-small cell lung cancer.31136816Friedberg JS, Culligan MJ, Tsao AS, Rusch V, Sepesi B, Pass HI, Bueno R, Burt B, Sugarbaker DJ, de Perrot M, Adjei AA, Adusumilli PS, Hirsch FR, Malik SM, Harpole DJJournal of thoracic oncology : official publication of the International Association for the Study of Lung CancerA Proposed System Toward Standardizing Surgical-Based Treatments for Malignant Pleural Mesothelioma, From the Joint National Cancer Institute-International Association for the Study of Lung Cancer-Mesothelioma Applied Research Foundation Taskforce. J Thorac Oncol. 2019 08; 14(8):1343-1353.J Thorac Oncol2019-05-25T00:00:002019A Proposed System Toward Standardizing Surgical-Based Treatments for Malignant Pleural Mesothelioma, From the Joint National Cancer Institute-International Association for the Study of Lung Cancer-Mesothelioma Applied Research Foundation Taskforce.Authorship 94886713Authorship 948908531179069Nelson DB, Rice DC, Mitchell KG, Tsao AS, Vaporciyan AA, Antonoff MB, Hofstetter WL, Walsh GL, Swisher SG, Roth JA, Gomez DR, Mehran RJ, Sepesi BJournal of thoracic diseaseDefining the role of adjuvant radiotherapy for malignant pleural mesothelioma: a propensity-matched landmark analysis of the National Cancer Database. J Thorac Dis. 2019 Apr; 11(4):1269-1278.J Thorac Dis2019-04-01T00:00:002019Defining the role of adjuvant radiotherapy for malignant pleural mesothelioma: a propensity-matched landmark analysis of the National Cancer Database.31181388Mitchell KG, Corsini EM, Van Haren RM, Walsh GL, Sepesi BInternational journal of surgery case reportsA case report of a midesophageal diverticulum mimicking a fibrovascular esophageal polyp. Int J Surg Case Rep. 2019; 59:205-207.Int J Surg Case Rep2019-05-31T00:00:002019A case report of a midesophageal diverticulum mimicking a fibrovascular esophageal polyp.Authorship 950961531261048Corsini EM, Maoz-Metzl D, Mitchell KG, Rice RD, Sepesi BInternational journal of surgery case reportsMediastinal esophageal leiomyosarcoma abutting a retroesophageal right subclavian artery: A case report. Int J Surg Case Rep. 2019; 60:281-283.Int J Surg Case Rep2019-06-26T00:00:002019Mediastinal esophageal leiomyosarcoma abutting a retroesophageal right subclavian artery: A case report.Authorship 95152714Authorship 95156218Authorship 951609531285952Baity M, Wang L, Correa AM, Zhang X, Zhang R, Pataer A, Wu S, Meng QH, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Zhao M, Gu J, Fang BAmerican journal of cancer researchGlutathione reductase (GSR) gene deletion and chromosome 8 aneuploidy in primary lung cancers detected by fluorescence in situ hybridization. Am J Cancer Res. 2019; 9(6):1201-1211.Am J Cancer Res2019-06-01T00:00:002019Glutathione reductase (GSR) gene deletion and chromosome 8 aneuploidy in primary lung cancers detected by fluorescence in situ hybridization.31287557Chen Y, Zhang R, Wang L, Correa AM, Pataer A, Xu Y, Zhang X, Ren C, Wu S, Meng QH, Fujimoto J, Jensen VB, Antonoff MB, Hofstetter WL, Mehran RJ, Pisimisis G, Rice DC, Sepesi B, Vaporciyan AA, Walsh GL, Swisher SG, Roth JA, Heymach JV, Fang BCancerTumor characteristics associated with engraftment of patient-derived non-small cell lung cancer xenografts in immunocompromised mice. Cancer. 2019 11 01; 125(21):3738-3748.Cancer2019-07-09T00:00:002019Tumor characteristics associated with engraftment of patient-derived non-small cell lung cancer xenografts in immunocompromised mice.31290159Corsini EM, Mitchell KG, Mehran RJ, Rice DC, Sepesi B, Walsh GL, Swisher SG, Roth JA, Hofstetter WL, Vaporciyan AA, Morris VK, Antonoff MBJournal of surgical oncologyColorectal cancer mutations are associated with survival and recurrence after pulmonary metastasectomy. J Surg Oncol. 2019 Sep; 120(4):729-735.J Surg Oncol2019-07-09T00:00:002019Colorectal cancer mutations are associated with survival and recurrence after pulmonary metastasectomy.Authorship 952138931313820Mitchell KG, Nelson DB, Corsini EM, Vaporciyan AA, Antonoff MB, Mehran RJ, Rice DC, Roth JA, Sepesi B, Walsh GL, Bhutani MS, Maru DM, Wu CC, Nguyen QN, Ajani JA, Swisher SG, Hofstetter WLDiseases of the esophagus : official journal of the International Society for Diseases of the EsophagusMorbidity following salvage esophagectomy for squamous cell carcinoma: the MD Anderson experience. Dis Esophagus. 2020 Mar 16; 33(3).Dis Esophagus2020-03-16T00:00:002020Morbidity following salvage esophagectomy for squamous cell carcinoma: the MD Anderson experience.Authorship 953529731395367Nelson DB, Tayob N, Nguyen QN, Erasmus J, Mitchell KG, Hofstetter WL, Sepesi B, Antonoff MB, Mehran RJThe Journal of thoracic and cardiovascular surgeryLocal failure after stereotactic body radiation therapy or wedge resection for colorectal pulmonary metastases. J Thorac Cardiovasc Surg. 2019 10; 158(4):1234-1241.e16.J Thorac Cardiovasc Surg2019-05-11T00:00:002019Local failure after stereotactic body radiation therapy or wedge resection for colorectal pulmonary metastases.Authorship 9541696Authorship 9543412Authorship 9543774Authorship 954415631442490Corsini EM, Sepesi BSeminars in thoracic and cardiovascular surgeryCommentary: Salvage Resection for Stage IIIA Lung Cancer in the Era of Immunotherapy. Semin Thorac Cardiovasc Surg. 2020; 32(1):160-161.Semin Thorac Cardiovasc Surg2019-08-20T00:00:002019Commentary: Salvage Resection for Stage IIIA Lung Cancer in the Era of Immunotherapy.31445908Nelson DB, Niu J, Mitchell KG, Sepesi B, Hofstetter WL, Antonoff MB, Giordano SH, Mehran RJ, Rice DCThe Annals of thoracic surgeryPersistent Opioid Use Among the Elderly After Lung Resection: A SEER-Medicare Study. Ann Thorac Surg. 2020 01; 109(1):194-202.Ann Thorac Surg2019-08-22T00:00:002019Persistent Opioid Use Among the Elderly After Lung Resection: A SEER-Medicare Study.31447303Mitchell KG, Farooqi A, Ludmir EB, Corsini EM, Zhang J, Sepesi B, Vaporciyan AA, Swisher SG, Heymach JV, Zhang J, Gomez DR, Antonoff MBClinical lung cancerImproved Overall Survival With Comprehensive Local Consolidative Therapy in Synchronous Oligometastatic Non-Small-Cell Lung Cancer. Clin Lung Cancer. 2020 01; 21(1):37-46.e7.Clin Lung Cancer2019-08-01T00:00:002019Improved Overall Survival With Comprehensive Local Consolidative Therapy in Synchronous Oligometastatic Non-Small-Cell Lung Cancer.31430846Nelson DB, Rice DC, Mitchell KG, Tsao AS, Gomez DR, Sepesi B, Mehran RJThe Journal of thoracic and cardiovascular surgeryReturn to intended oncologic treatment after surgery for malignant pleural mesothelioma. J Thorac Cardiovasc Surg. 2019 09; 158(3):924-929.J Thorac Cardiovasc Surg2019-04-16T00:00:002019Return to intended oncologic treatment after surgery for malignant pleural mesothelioma.Authorship 9558211431539514Shewale JB, Correa AM, Brown EL, Leon-Novelo LG, Nyitray AG, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Walsh GL, Roth J, Vaporciyan AA, Swisher SG, Sepesi BThe Annals of thoracic surgeryTime Trends of Perioperative Outcomes in Early Stage Non-Small Cell Lung Cancer Resection Patients. Ann Thorac Surg. 2020 02; 109(2):404-411.Ann Thorac Surg2019-09-17T00:00:002019Time Trends of Perioperative Outcomes in Early Stage Non-Small Cell Lung Cancer Resection Patients.Authorship 95595617Authorship 956129631550464Mitchell KG, Negrao MV, Parra ER, Li J, Zhang J, Dejima H, Vaporciyan AA, Swisher SG, Weissferdt A, Antonoff MB, Cascone T, Roarty E, Wistuba II, Heymach JV, Gibbons DL, Zhang J, Sepesi BThe Annals of thoracic surgeryLymphovascular Invasion Is Associated With Mutational Burden and PD-L1 in Resected Lung Cancer. Ann Thorac Surg. 2020 02; 109(2):358-366.Ann Thorac Surg2019-09-21T00:00:002019Lymphovascular Invasion Is Associated With Mutational Burden and PD-L1 in Resected Lung Cancer.31559043Corsini EM, Mitchell KG, Sceusi EL, Mehran RJ, Rice DC, Sepesi B, Walsh GL, Swisher SG, Roth JA, Vaporciyan AA, Hofstetter WL, Antonoff MBJournal of thoracic diseaseMultidisciplinary treatment of thymic neuroendocrine tumors: surgery remains a key component. J Thorac Dis. 2019 Aug; 11(8):3391-3398.J Thorac Dis2019-08-01T00:00:002019Multidisciplinary treatment of thymic neuroendocrine tumors: surgery remains a key component.Authorship 9575231Authorship 957815131629501Sepesi BThe Journal of thoracic and cardiovascular surgeryCommentary: Surgery for N3 non-small cell lung cancer-utopia or future reality? J Thorac Cardiovasc Surg. 2019 12; 158(6):1693-1694.J Thorac Cardiovasc Surg2019-09-23T00:00:002019Commentary: Surgery for N3 non-small cell lung cancer-utopia or future reality?31648835Sepesi B, Cascone TThe Journal of thoracic and cardiovascular surgeryCommentary: Neoadjuvant checkpoint inhibitors in resectable non-small cell lung cancer-Ready for prime time? J Thorac Cardiovasc Surg. 2020 04; 159(4):1624-1625.J Thorac Cardiovasc Surg2019-09-24T00:00:002019Commentary: Neoadjuvant checkpoint inhibitors in resectable non-small cell lung cancer-Ready for prime time?Authorship 962874731857153Van Haren RM, Rajaram R, Correa AM, Mehran RJ, Antonoff MB, Hofstetter WL, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Rice DC, Roth JASeminars in thoracic and cardiovascular surgeryPreoperative Heparin for Lung Cancer Resection Increases Risk of Reoperation for Bleeding. Semin Thorac Cardiovasc Surg. 2020 Summer; 32(2):337-343.Semin Thorac Cardiovasc Surg2019-12-17T00:00:002019Preoperative Heparin for Lung Cancer Resection Increases Risk of Reoperation for Bleeding.Authorship 97465515Authorship 9746911031875755Mitchell KG, Nelson DB, Corsini EM, Correa AM, Erasmus JJ, Hofstetter WL, Mehran RJ, Roth JA, Swisher SG, Sepesi B, Walsh GL, Vaporciyan AA, Rice DC, Nguyen QN, Antonoff MBInnovations (Philadelphia, Pa.)Surveillance After Treatment of Non-Small-Cell Lung Cancer: A Call for Multidisciplinary Standardization. Innovations (Phila). 2020 Jan/Feb; 15(1):57-65.Innovations (Phila)2019-12-26T00:00:002019Surveillance After Treatment of Non-Small-Cell Lung Cancer: A Call for Multidisciplinary Standardization.31873309Goswami S, Walle T, Cornish AE, Basu S, Anandhan S, Fernandez I, Vence L, Blando J, Zhao H, Yadav SS, Ott M, Kong LY, Heimberger AB, de Groot J, Sepesi B, Overman M, Kopetz S, Allison JP, Pe'er D, Sharma PNature medicineImmune profiling of human tumors identifies CD73 as a combinatorial target in glioblastoma. Nat Med. 2020 01; 26(1):39-46.Nat Med2019-12-23T00:00:002019Immune profiling of human tumors identifies CD73 as a combinatorial target in glioblastoma.Authorship 9767814632001676Reuben A, Zhang J, Chiou SH, Gittelman RM, Li J, Lee WC, Fujimoto J, Behrens C, Liu X, Wang F, Quek K, Wang C, Kheradmand F, Chen R, Chow CW, Lin H, Bernatchez C, Jalali A, Hu X, Wu CJ, Eterovic AK, Parra ER, Yusko E, Emerson R, Benzeno S, Vignali M, Wu X, Ye Y, Little LD, Gumbs C, Mao X, Song X, Tippen S, Thornton RL, Cascone T, Snyder A, Wargo JA, Herbst R, Swisher S, Kadara H, Moran C, Kalhor N, Zhang J, Scheet P, Vaporciyan AA, Sepesi B, Gibbons DL, Robins H, Hwu P, Heymach JV, Sharma P, Allison JP, Baladandayuthapani V, Lee JJ, Davis MM, Wistuba II, Futreal PA, Zhang JNature communicationsComprehensive T cell repertoire characterization of non-small cell lung cancer. Nat Commun. 2020 01 30; 11(1):603.Nat Commun2020-01-30T00:00:002020Comprehensive T cell repertoire characterization of non-small cell lung cancer.Authorship 9781161032077113Corsini EM, Datar SS, Mitchell KG, Zhou N, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Blackmon SH, Loree JM, Morris VK, Antonoff MBJournal of surgical oncologyHigh mutational concordance between primary colorectal tumors and associated pulmonary metastases. J Surg Oncol. 2020 May; 121(6):984-989.J Surg Oncol2020-02-19T00:00:002020High mutational concordance between primary colorectal tumors and associated pulmonary metastases.Authorship 9784291832089476Rajaram R, Correa AM, Xu T, Nguyen QN, Antonoff MB, Rice D, Mehran R, Roth J, Walsh G, Swisher S, Hofstetter WL, Vaporciyan A, Cascone T, Tsao AS, Papadimitrakopoulou VA, Gandhi S, Liao Z, Sepesi BClinical lung cancerLocoregional Control, Overall Survival, and Disease-Free Survival in Stage IIIA (N2) Non-Small-Cell Lung Cancer: Analysis of Resected and Unresected Patients. Clin Lung Cancer. 2020 07; 21(4):e294-e301.Clin Lung Cancer2020-01-27T00:00:002020Locoregional Control, Overall Survival, and Disease-Free Survival in Stage IIIA (N2) Non-Small-Cell Lung Cancer: Analysis of Resected and Unresected Patients.Authorship 9794652Authorship 9799163032145220Moran CA, Lindholm KE, Brunnstr?m H, Langman G, Jang SJ, Spagnolo D, Chai SM, Laycock A, Falconieri G, Pizzolitto S, de Pellegrin A, Medeiros F, Edmunds L, Catarino A, Cunha F, Ro J, Pina-Oviedo S, Torrealba J, Coppola D, Petersson F, Oon ML, Elmberger G, Y Cajal SR, Valero IS, Dalurzo L, Soares F, Campos AH, Vranic S, Skenderi F, Correa AM, Sepesi B, Rice D, Mehran R, Walsh GHuman pathologyTypical and atypical carcinoid tumors of the lung: a clinicopathological correlation of 783 cases with emphasis on histological features. Hum Pathol. 2020 04; 98:98-109.Hum Pathol2020-03-05T00:00:002020Typical and atypical carcinoid tumors of the lung: a clinicopathological correlation of 783 cases with emphasis on histological features.32193228Cascone T, Sepesi B, Lin HY, Kalhor N, Parra ER, Jiang M, Godoy MCB, Zhang J, Fossella FV, Tsao AS, Lam VK, Lu C, Mott FE, Simon GR, Antonoff MB, Mehran RJ, Rice DC, Behrens C, Weissferdt A, Moran C, Vaporciyan AA, Lee JJ, Swisher SG, Gibbons DL, Wistuba II, William WN, Heymach JVClinical cancer research : an official journal of the American Association for Cancer ResearchA Phase I/II Study of Neoadjuvant Cisplatin, Docetaxel, and Nintedanib for Resectable Non-Small Cell Lung Cancer. Clin Cancer Res. 2020 07 15; 26(14):3525-3536.Clin Cancer Res2020-03-19T00:00:002020A Phase I/II Study of Neoadjuvant Cisplatin, Docetaxel, and Nintedanib for Resectable Non-Small Cell Lung Cancer.Authorship 9861691232229762Rice D, Rodriguez-Restrepo A, Mena G, Cata J, Thall P, Milton D, Correa A, Woodard T, Antonoff M, Hofstetter W, Roth J, Sepesi B, Swisher S, Walsh G, Vaporciyan A, Mehran RAnnals of surgeryMatched Pairs Comparison of an Enhanced Recovery Pathway Versus Conventional Management on Opioid Exposure and Pain Control in Patients Undergoing Lung Surgery. Ann Surg. 2021 12 01; 274(6):1099-1106.Ann Surg2021-12-01T00:00:002021Matched Pairs Comparison of an Enhanced Recovery Pathway Versus Conventional Management on Opioid Exposure and Pain Control in Patients Undergoing Lung Surgery.Authorship 9868143Authorship 986831932274083Van Haren RM, Correa AM, Sepesi B, Rice DC, Hofstetter WL, Roth JA, Swisher SG, Walsh GL, Vaporciyan AA, Mehran RJ, Antonoff MBJournal of thoracic diseaseHospital readmissions after pulmonary resection: post-discharge nursing telephone assessment identifies high risk patients. J Thorac Dis. 2020 Mar; 12(3):184-190.J Thorac Dis2020-03-01T00:00:002020Hospital readmissions after pulmonary resection: post-discharge nursing telephone assessment identifies high risk patients.32274099Nelson DB, Mitchell KG, Wang J, Fujimoto J, Godoy M, Behrens C, Zheng X, Zhang J, Sepesi B, Vaporciyan AA, Hofstetter WL, Mehran RJ, Rice DC, Walsh GL, Swisher SG, Moran CA, Kalhor N, Weissferdt A, Wistuba II, Roth JA, Antonoff MBJournal of thoracic diseaseImmune regulatory markers of lepidic-pattern adenocarcinomas presenting as ground glass opacities. J Thorac Dis. 2020 Mar; 12(3):329-337.J Thorac Dis2020-03-01T00:00:002020Immune regulatory markers of lepidic-pattern adenocarcinomas presenting as ground glass opacities.Authorship 9872515Authorship 98755114Authorship 987984532279936Weissferdt A, Pataer A, Vaporciyan AA, Correa AM, Sepesi B, Moran CA, Wistuba II, Roth JA, Shewale JB, Heymach JV, Kalhor N, Cascone T, Hofstetter WL, Lee JJ, Swisher SGClinical lung cancerAgreement on Major Pathological Response in NSCLC Patients Receiving Neoadjuvant Chemotherapy. Clin Lung Cancer. 2020 07; 21(4):341-348.Clin Lung Cancer2020-03-04T00:00:002020Agreement on Major Pathological Response in NSCLC Patients Receiving Neoadjuvant Chemotherapy.32331820Mitchell KG, Farooqi A, Ludmir EB, Corsini EM, Sepesi B, Gomez DR, Antonoff MB, MD Anderson Cancer Center Oligometastatic Lung Cancer Working GroupThe Journal of thoracic and cardiovascular surgeryPulmonary resection is associated with long-term survival and should remain a therapeutic option in oligometastatic lung cancer. J Thorac Cardiovasc Surg. 2021 Apr; 161(4):1497-1504.e2.J Thorac Cardiovasc Surg2020-03-25T00:00:002020Pulmonary resection is associated with long-term survival and should remain a therapeutic option in oligometastatic lung cancer.32300858Mitchell KG, Amini B, Wang Y, Carter BW, Godoy MCB, Parra ER, Behrens C, Villalobos P, Reuben A, Lee JJ, Weissferdt A, Moran CA, Fujimoto J, Sepesi B, Walsh GL, Vaporciyan AA, Hofstetter WL, William WN, Gibbons DL, Wang J, Hwu P, Swisher SG, Piwnica-Worms D, Kadara H, Wistuba II, Heymach JV, Peng W, Cascone TCancer immunology, immunotherapy : CII18F-fluorodeoxyglucose positron emission tomography correlates with tumor immunometabolic phenotypes in resected lung cancer. Cancer Immunol Immunother. 2020 Aug; 69(8):1519-1534.Cancer Immunol Immunother2020-04-16T00:00:00202018F-fluorodeoxyglucose positron emission tomography correlates with tumor immunometabolic phenotypes in resected lung cancer.Authorship 9881746Authorship 98835623Authorship 9884401532340682Friedberg JS, Culligan MJ, Tsao AS, Rusch V, Adusumilli PS, Sepesi B, Pass HI, Bueno R, Burt B, Sugarbaker DJ, de Perrot M, Adjei AA, Hirsch FR, Malik SM, Harpole DJJournal of thoracic oncology : official publication of the International Association for the Study of Lung CancerReply to Waller et?al. Standardizing Surgical Treatment for Mesothelioma. J Thorac Oncol. 2020 05; 15(5):e75-e77.J Thorac Oncol2020-05-01T00:00:002020Reply to Waller et?al. Standardizing Surgical Treatment for Mesothelioma.32350118Mitchell KG, Diao L, Karpinets T, Negrao MV, Tran HT, Parra ER, Corsini EM, Reuben A, Federico L, Bernatchez C, Dejima H, Francisco-Cruz A, Wang J, Antonoff MB, Vaporciyan AA, Swisher SG, Cascone T, Wistuba II, Heymach JV, Gibbons DL, Zhang J, Haymaker CL, Sepesi BJournal for immunotherapy of cancerNeutrophil expansion defines an immunoinhibitory peripheral and intratumoral inflammatory milieu in resected non-small cell lung cancer: a descriptive analysis of a prospectively immunoprofiled cohort. J Immunother Cancer. 2020 04; 8(1).J Immunother Cancer2020-04-01T00:00:002020Neutrophil expansion defines an immunoinhibitory peripheral and intratumoral inflammatory milieu in resected non-small cell lung cancer: a descriptive analysis of a prospectively immunoprofiled cohort.32356321Shewale JB, Corsini EM, Correa AM, Brown EL, Leon-Novelo LG, Nyitray AG, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Roth J, Walsh GL, Vaporciyan AA, Swisher SG, Sepesi BJournal of surgical oncologyTime trends and predictors of survival in surgically resected early-stage non-small cell lung cancer patients. J Surg Oncol. 2020 Sep; 122(3):495-505.J Surg Oncol2020-04-30T00:00:002020Time trends and predictors of survival in surgically resected early-stage non-small cell lung cancer patients.Authorship 98921815Authorship 9892461432389639Hong L, Negrao MV, Dibaj SS, Chen R, Reuben A, Bohac JM, Liu X, Skoulidis F, Gay CM, Cascone T, Mitchell KG, Tran HT, Le X, Byers LA, Sepesi B, Altan M, Elamin YY, Fossella FV, Kurie JM, Lu C, Mott FE, Tsao AS, Rinsurongkawong W, Lewis J, Gibbons DL, Glisson BS, Blumenschein GR, Roarty EB, Futreal PA, Wistuba II, Roth JA, Swisher SG, Papadimitrakopoulou VA, Heymach JV, Lee JJ, Simon GR, Zhang JJournal of thoracic oncology : official publication of the International Association for the Study of Lung CancerProgrammed Death-Ligand 1 Heterogeneity and Its Impact on Benefit From Immune Checkpoint Inhibitors in NSCLC. J Thorac Oncol. 2020 09; 15(9):1449-1459.J Thorac Oncol2020-05-08T00:00:002020Programmed Death-Ligand 1 Heterogeneity and Its Impact on Benefit From Immune Checkpoint Inhibitors in NSCLC.32391280Wang Y, Zheng Q, Jia B, An T, Zhao J, Wu M, Zhuo M, Li J, Zhong J, Chen H, Yang X, Chi Y, Dong Z, Sepesi B, Zhang J, Gay CM, Wang ZFrontiers in oncologyEffects of Surgery on Survival of Early-Stage Patients With SCLC: Propensity Score Analysis and Nomogram Construction in SEER Database. Front Oncol. 2020; 10:626.Front Oncol2020-04-24T00:00:002020Effects of Surgery on Survival of Early-Stage Patients With SCLC: Propensity Score Analysis and Nomogram Construction in SEER Database.Authorship 990454632468580Corsini EM, Mitchell KG, Hofstetter WL, Mehran RJ, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Antonoff MB, Rice DCJournal of surgical oncologyImportance of resection for locoregional disease control in Masaoka stage IVA thymic neoplasms. J Surg Oncol. 2020 Sep; 122(3):515-522.J Surg Oncol2020-05-28T00:00:002020Importance of resection for locoregional disease control in Masaoka stage IVA thymic neoplasms.Authorship 9932432232619781Corsini EM, Wang Q, Tran HT, Mitchell KG, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Reuben A, Vasquez ME, Bernatchez C, Wang J, Cascone T, Zhang J, Heymach JV, Gibbons DL, Haymaker CL, Sepesi BLung cancer (Amsterdam, Netherlands)Peripheral cytokines are not influenced by the type of surgical approach for non-small cell lung cancer by four weeks postoperatively. Lung Cancer. 2020 08; 146:303-309.Lung Cancer2020-06-27T00:00:002020Peripheral cytokines are not influenced by the type of surgical approach for non-small cell lung cancer by four weeks postoperatively.Authorship 9938692132642098Corsini EM, Wang J, Wu CC, Fujimoto J, Negrao MV, Chen R, Quek K, Mitchell KG, Chow CB, Little L, Gumbs C, Song X, Behrens C, Correa AM, Antonoff MB, Swisher SG, Heymach JV, Zhang J, Wistuba II, Futreal PA, Sepesi B, Zhang JJournal of thoracic diseaseGenomic assessment distinguishes intrapulmonary metastases from synchronous primary lung cancers. J Thorac Dis. 2020 May; 12(5):1952-1959.J Thorac Dis2020-05-01T00:00:002020Genomic assessment distinguishes intrapulmonary metastases from synchronous primary lung cancers.Authorship 9962302Authorship 9962431032763029Stiles BM, Sepesi B, Broderick SR, Bott MJThe Journal of thoracic and cardiovascular surgeryPerioperative considerations for neoadjuvant immunotherapy in non-small cell lung cancer. J Thorac Cardiovasc Surg. 2020 Nov; 160(5):1376-1382.J Thorac Cardiovasc Surg2020-07-05T00:00:002020Perioperative considerations for neoadjuvant immunotherapy in non-small cell lung cancer.32763065Behrens C, Rocha P, Parra ER, Feng L, Rodriguez-Canales J, Solis LM, Mino B, Zhang J, Gibbons DL, Sepesi B, Rice D, Heymach JV, Moran C, Creighton CJ, Lee JJ, Kadara H, Wistuba IIClinical lung cancerFemale Gender Predicts Augmented Immune Infiltration in Lung Adenocarcinoma. Clin Lung Cancer. 2021 05; 22(3):e415-e424.Clin Lung Cancer2020-06-14T00:00:002020Female Gender Predicts Augmented Immune Infiltration in Lung Adenocarcinoma.Authorship 997457932816946Chen R, Lee WC, Fujimoto J, Li J, Hu X, Mehran R, Rice D, Swisher SG, Sepesi B, Tran HT, Chow CW, Little LD, Gumbs C, Haymaker C, Heymach JV, Wistuba II, Lee JJ, Futreal PA, Zhang J, Reuben A, Tsao AS, Zhang JClinical cancer research : an official journal of the American Association for Cancer ResearchEvolution of Genomic and T-cell Repertoire Heterogeneity of Malignant Pleural Mesothelioma Under Dasatinib Treatment. Clin Cancer Res. 2020 10 15; 26(20):5477-5486.Clin Cancer Res2020-08-14T00:00:002020Evolution of Genomic and T-cell Repertoire Heterogeneity of Malignant Pleural Mesothelioma Under Dasatinib Treatment.Authorship 998197832857997Corsini EM, Mitchell KG, Zhou N, Antonoff MB, Mehran RJ, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Maru DM, Lin SH, Ajani JA, Hofstetter WLThe Annals of thoracic surgeryModified En Bloc Esophagectomy Compared With Standard Resection After Neoadjuvant Chemoradiation. Ann Thorac Surg. 2021 04; 111(4):1133-1140.Ann Thorac Surg2020-08-25T00:00:002020Modified En Bloc Esophagectomy Compared With Standard Resection After Neoadjuvant Chemoradiation.Authorship 99845616Authorship 998633132864702Corsini EM, Weissferdt A, Pataer A, Zhou N, Antonoff MB, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Cascone T, Heymach JV, Swisher SG, Sepesi BEuropean journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic SurgeryPathological nodal disease defines survival outcomes in patients with lung cancer with tumour major pathological response following neoadjuvant chemotherapy. Eur J Cardiothorac Surg. 2021 01 04; 59(1):100-108.Eur J Cardiothorac Surg2021-01-04T00:00:002021Pathological nodal disease defines survival outcomes in patients with lung cancer with tumour major pathological response following neoadjuvant chemotherapy.32883458Sepesi B, Cascone T, Chun SG, Altan M, Le XSurgical oncology clinics of North AmericaEmerging Therapies in Thoracic Malignancies-Immunotherapy, Targeted Therapy, and T-Cell Therapy in Non-Small Cell Lung Cancer. Surg Oncol Clin N Am. 2020 10; 29(4):555-569.Surg Oncol Clin N Am2020-07-29T00:00:002020Emerging Therapies in Thoracic Malignancies-Immunotherapy, Targeted Therapy, and T-Cell Therapy in Non-Small Cell Lung Cancer.Authorship 10007808Authorship 1000921733003262Nelson DB, Niu J, Mitchell KG, Antonoff MB, Giordano SH, Hofstetter WL, Vaporciyan AA, Sepesi B, Mehran RJ, Rice DCThe Journal of thoracic and cardiovascular surgeryPerioperative outcomes among chronic opioid users who receive lobectomy for non-small cell lung cancer. J Thorac Cardiovasc Surg. 2020 02; 159(2):691-702.e5.J Thorac Cardiovasc Surg2019-09-27T00:00:002019Perioperative outcomes among chronic opioid users who receive lobectomy for non-small cell lung cancer.32980327Corsini EM, Zhou N, Antonoff MB, Mehran RJ, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Hofstetter WLThe Annals of thoracic surgeryPostoperative Bleeding and Acute Kidney Injury in Esophageal Cancer Patients Receiving Ketorolac. Ann Thorac Surg. 2021 04; 111(4):1111-1117.Ann Thorac Surg2020-09-24T00:00:002020Postoperative Bleeding and Acute Kidney Injury in Esophageal Cancer Patients Receiving Ketorolac.Authorship 10020181633010880Corsini EM, Foo WC, Mitchell KG, Zhou N, Maru DM, Ajani JA, Hofstetter WL, Esophageal Adenocarcinoma Working Group, Correa AM, Antonoff MB, Lin SH, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GLThe Journal of thoracic and cardiovascular surgeryEsophageal adenocarcinoma with any component of signet ring cells portends poor prognosis and response to neoadjuvant therapy. J Thorac Cardiovasc Surg. 2021 Nov; 162(5):1404-1412.e2.J Thorac Cardiovasc Surg2020-09-05T00:00:002020Esophageal adenocarcinoma with any component of signet ring cells portends poor prognosis and response to neoadjuvant therapy.Authorship 10034273633096269Gaudreau PO, Negrao MV, Mitchell KG, Reuben A, Corsini EM, Li J, Karpinets TV, Wang Q, Diao L, Wang J, Federico L, Parra-Cuentas ER, Khairullah R, Behrens C, Correa AM, Gomez D, Little L, Gumbs C, Kadara HN, Fujimoto J, McGrail DJ, Vaporciyan AA, Swisher SG, Walsh G, Antonoff MB, Weissferdt A, Tran H, Roarty E, Haymaker C, Bernatchez C, Zhang J, Futreal PA, Wistuba II, Cascone T, Heymach JV, Sepesi B, Zhang J, Gibbons DLJournal of thoracic oncology : official publication of the International Association for the Study of Lung CancerNeoadjuvant Chemotherapy Increases Cytotoxic T Cell, Tissue Resident Memory T Cell, and B Cell Infiltration in Resectable NSCLC. J Thorac Oncol. 2021 01; 16(1):127-139.J Thorac Oncol2020-10-21T00:00:002020Neoadjuvant Chemotherapy Increases Cytotoxic T Cell, Tissue Resident Memory T Cell, and B Cell Infiltration in Resectable NSCLC.Authorship 1004280933129774Corsini EM, Mitchell KG, Zhou N, Antonoff MB, Mehran RJ, Mena GE, Rajaram R, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Rice DC, Hofstetter WLThe Annals of thoracic surgeryLiposomal Bupivacaine Intercostal Block Is Important for Reduction of Pulmonary Complications. Ann Thorac Surg. 2021 08; 112(2):423-429.Ann Thorac Surg2020-10-28T00:00:002020Liposomal Bupivacaine Intercostal Block Is Important for Reduction of Pulmonary Complications.Authorship 1007465733349449Zhou N, Bott M, Park BJ, Valli?res E, Wilshire CL, Yasufuku K, Spicer JD, Jones DR, Sepesi B, Small Cell Lung Cancer Working GroupThe Journal of thoracic and cardiovascular surgeryPredictors of survival following surgical resection of limited-stage small cell lung cancer. J Thorac Cardiovasc Surg. 2021 Mar; 161(3):760-771.e2.J Thorac Cardiovasc Surg2020-11-27T00:00:002020Predictors of survival following surgical resection of limited-stage small cell lung cancer.Authorship 100811422Authorship 10084781833388477Le X, Negrao MV, Reuben A, Federico L, Diao L, McGrail D, Nilsson M, Robichaux J, Munoz IG, Patel S, Elamin Y, Fan YH, Lee WC, Parra E, Solis Soto LM, Chen R, Li J, Karpinets T, Khairullah R, Kadara H, Behrens C, Sepesi B, Wang R, Zhu M, Wang L, Vaporciyan A, Roth J, Swisher S, Haymaker C, Zhang J, Wang J, Wong KK, Byers LA, Bernatchez C, Zhang J, Wistuba II, Gibbons DL, Akbay EA, Heymach JVJournal of thoracic oncology : official publication of the International Association for the Study of Lung CancerCharacterization of the Immune Landscape of EGFR-Mutant NSCLC Identifies CD73/Adenosine Pathway as a Potential Therapeutic Target. J Thorac Oncol. 2021 04; 16(4):583-600.J Thorac Oncol2020-12-31T00:00:002020Characterization of the Immune Landscape of EGFR-Mutant NSCLC Identifies CD73/Adenosine Pathway as a Potential Therapeutic Target.33416944Rocha P, Salazar R, Zhang J, Ledesma D, Solorzano JL, Mino B, Villalobos P, Dejima H, Douse DY, Diao L, Mitchell KG, Le X, Zhang J, Weissferdt A, Parra-Cuentas E, Cascone T, Rice DC, Sepesi B, Kalhor N, Moran C, Vaporciyan A, Heymach J, Gibbons DL, Lee JJ, Kadara H, Wistuba I, Behrens C, Solis LMCancer immunology, immunotherapy : CIICD73 expression defines immune, molecular, and clinicopathological subgroups of lung adenocarcinoma. Cancer Immunol Immunother. 2021 Jul; 70(7):1965-1976.Cancer Immunol Immunother2021-01-08T00:00:002021CD73 expression defines immune, molecular, and clinicopathological subgroups of lung adenocarcinoma.Authorship 10101261833514726Hu X, Estecio MR, Chen R, Reuben A, Wang L, Fujimoto J, Carrot-Zhang J, McGranahan N, Ying L, Fukuoka J, Chow CW, Pham HHN, Godoy MCB, Carter BW, Behrens C, Zhang J, Antonoff MB, Sepesi B, Lu Y, Pass HI, Kadara H, Scheet P, Vaporciyan AA, Heymach JV, Wistuba II, Lee JJ, Futreal PA, Su D, Issa JJ, Zhang JNature communicationsEvolution of DNA methylome from precancerous lesions to invasive lung adenocarcinomas. Nat Commun. 2021 01 29; 12(1):687.Nat Commun2021-01-29T00:00:002021Evolution of DNA methylome from precancerous lesions to invasive lung adenocarcinomas.Authorship 10109199Authorship 1011137333569339Pradhan M, Chocry M, Gibbons DL, Sepesi B, Cascone TTranslational lung cancer researchEmerging biomarkers for neoadjuvant immune checkpoint inhibitors in operable non-small cell lung cancer. Transl Lung Cancer Res. 2021 Jan; 10(1):590-606.Transl Lung Cancer Res2021-01-01T00:00:002021Emerging biomarkers for neoadjuvant immune checkpoint inhibitors in operable non-small cell lung cancer.33555525Corsini EM, Mitchell KG, Zhou N, Antonoff MB, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Hofstetter WLJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary TractIntestinal Metaplasia in the Esophageal Remnant Is Rare After Ivor Lewis Esophagectomy. J Gastrointest Surg. 2021 09; 25(9):2185-2191.J Gastrointest Surg2021-02-08T00:00:002021Intestinal Metaplasia in the Esophageal Remnant Is Rare After Ivor Lewis Esophagectomy.Authorship 101182253Authorship 10123227Authorship 10123371433603241Cascone T, William WN, Weissferdt A, Leung CH, Lin HY, Pataer A, Godoy MCB, Carter BW, Federico L, Reuben A, Khan MAW, Dejima H, Francisco-Cruz A, Parra ER, Solis LM, Fujimoto J, Tran HT, Kalhor N, Fossella FV, Mott FE, Tsao AS, Blumenschein G, Le X, Zhang J, Skoulidis F, Kurie JM, Altan M, Lu C, Glisson BS, Byers LA, Elamin YY, Mehran RJ, Rice DC, Walsh GL, Hofstetter WL, Roth JA, Antonoff MB, Kadara H, Haymaker C, Bernatchez C, Ajami NJ, Jenq RR, Sharma P, Allison JP, Futreal A, Wargo JA, Wistuba II, Swisher SG, Lee JJ, Gibbons DL, Vaporciyan AA, Heymach JV, Sepesi BNature medicineNeoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial. Nat Med. 2021 03; 27(3):504-514.Nat Med2021-02-18T00:00:002021Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial.33631448Weissferdt A, Pataer A, Swisher SG, Heymach JV, Gibbons DL, Cascone T, Sepesi BLung cancer (Amsterdam, Netherlands)Controversies and challenges in the pathologic examination of lung resection specimens after neoadjuvant treatment. Lung Cancer. 2021 04; 154:76-83.Lung Cancer2021-02-17T00:00:002021Controversies and challenges in the pathologic examination of lung resection specimens after neoadjuvant treatment.33633208Parra ER, Zhai J, Tamegnon A, Zhou N, Pandurengan RK, Barreto C, Jiang M, Rice DC, Creasy C, Vaporciyan AA, Hofstetter WL, Tsao AS, Wistuba II, Sepesi B, Haymaker CScientific reportsIdentification of distinct immune landscapes using an automated nine-color multiplex immunofluorescence staining panel and image analysis in paraffin tumor tissues. Sci Rep. 2021 02 25; 11(1):4530.Sci Rep2021-02-25T00:00:002021Identification of distinct immune landscapes using an automated nine-color multiplex immunofluorescence staining panel and image analysis in paraffin tumor tissues.Authorship 10134527Authorship 10134921833684226Feldman HA, Zhou N, Antonoff MB, Hofstetter WL, Rajaram R, Rice DC, Sepesi B, Vaporciyan AA, Zorrilla-Vaca A, Mehran RJJournal of surgical oncologySimultaneous versus staged resections for bilateral pulmonary metastases. J Surg Oncol. 2021 Jun; 123(7):1633-1639.J Surg Oncol2021-03-08T00:00:002021Simultaneous versus staged resections for bilateral pulmonary metastases.33686493Rocha P, Salazar R, Zhang J, Ledesma D, Solorzano JL, Mino B, Villalobos P, Dejima H, Douse DY, Diao L, Mitchell KG, Le X, Zhang J, Weissferdt A, Parra-Cuentas E, Cascone T, Rice DC, Sepesi B, Kalhor N, Moran C, Vaporciyan A, Heymach J, Gibbons DL, Lee JJ, Kadara H, Wistuba I, Behrens C, Solis LMCancer immunology, immunotherapy : CIICorrection to: CD73 expression defines immune, molecular, and clinicopathological subgroups of lung adenocarcinoma. Cancer Immunol Immunother. 2021 Jul; 70(7):1977-1978.Cancer Immunol Immunother2021-07-01T00:00:002021Correction to: CD73 expression defines immune, molecular, and clinicopathological subgroups of lung adenocarcinoma.Authorship 10153268Authorship 10158221433774003Olive JK, Zhou N, Mitchell KG, Corsini EM, Hofstetter WL, Mehran RJ, Rice DC, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Antonoff MBThe Annals of thoracic surgeryImpact of Psychiatric Comorbidities on Surgical Outcomes for Non-Small Cell Lung?Cancer. Ann Thorac Surg. 2022 03; 113(3):1008-1014.Ann Thorac Surg2021-03-25T00:00:002021Impact of Psychiatric Comorbidities on Surgical Outcomes for Non-Small Cell Lung?Cancer.33809063Han G, Sinjab A, Hara K, Treekitkarnmongkol W, Brennan P, Chang K, Bogatenkova E, Sanchez-Espiridion B, Behrens C, Solis LM, Gao B, Girard L, Zhang J, Sepesi B, Cascone T, Byers LA, Gibbons DL, Chen J, Moghaddam SJ, Ostrin EJ, Scheet P, Fujimoto J, Shay J, Heymach JV, Minna JD, Dubinett S, Wistuba II, Stevenson CS, Spira AE, Wang L, Kadara HCancersSingle-Cell Expression Landscape of SARS-CoV-2 Receptor ACE2 and Host Proteases in Normal and Malignant Lung Tissues from Pulmonary Adenocarcinoma Patients. Cancers (Basel). 2021 Mar 12; 13(6).Cancers (Basel)2021-03-12T00:00:002021Single-Cell Expression Landscape of SARS-CoV-2 Receptor ACE2 and Host Proteases in Normal and Malignant Lung Tissues from Pulmonary Adenocarcinoma Patients.Authorship 10160868Authorship 1016397533838123Zhou N, Corsini EM, Antonoff MB, Hofstetter WL, Mehran RJ, Rajaram R, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Rice DCThe Annals of thoracic surgeryRobotic Surgery and Anatomic Segmentectomy: An Analysis of Trends, Patient Selection, and Outcomes. Ann Thorac Surg. 2022 03; 113(3):975-983.Ann Thorac Surg2021-04-07T00:00:002021Robotic Surgery and Anatomic Segmentectomy: An Analysis of Trends, Patient Selection, and Outcomes.33857666Pataer A, Weissferdt A, Vaporciyan AA, Correa AM, Sepesi B, Wistuba II, Heymach JV, Cascone T, Swisher SGJournal of thoracic oncology : official publication of the International Association for the Study of Lung CancerEvaluation of Pathologic Response in Lymph Nodes of Patients With Lung Cancer Receiving Neoadjuvant Chemotherapy. J Thorac Oncol. 2021 08; 16(8):1289-1297.J Thorac Oncol2021-04-20T00:00:002021Evaluation of Pathologic Response in Lymph Nodes of Patients With Lung Cancer Receiving Neoadjuvant Chemotherapy.Authorship 101819415Authorship 101821426Authorship 10182942533971174Zhou N, Rice DC, Tsao AS, Lee PP, Haymaker CL, Corsini EM, Antonoff MB, Hofstetter WL, Rajaram R, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Mehran RJ, Sepesi BThe Annals of thoracic surgeryExtrapleural Pneumonectomy Versus Pleurectomy/Decortication for Malignant Pleural Mesothelioma. Ann Thorac Surg. 2022 01; 113(1):200-208.Ann Thorac Surg2021-05-08T00:00:002021Extrapleural Pneumonectomy Versus Pleurectomy/Decortication for Malignant Pleural Mesothelioma.33972311Sinjab A, Han G, Treekitkarnmongkol W, Hara K, Brennan PM, Dang M, Hao D, Wang R, Dai E, Dejima H, Zhang J, Bogatenkova E, Sanchez-Espiridion B, Chang K, Little DR, Bazzi S, Tran LM, Krysan K, Behrens C, Duose DY, Parra ER, Raso MG, Solis LM, Fukuoka J, Zhang J, Sepesi B, Cascone T, Byers LA, Gibbons DL, Chen J, Moghaddam SJ, Ostrin EJ, Rosen D, Heymach JV, Scheet P, Dubinett SM, Fujimoto J, Wistuba II, Stevenson CS, Spira A, Wang L, Kadara HCancer discoveryResolving the Spatial and Cellular Architecture of Lung Adenocarcinoma by Multiregion Single-Cell Sequencing. Cancer Discov. 2021 10; 11(10):2506-2523.Cancer Discov2021-05-10T00:00:002021Resolving the Spatial and Cellular Architecture of Lung Adenocarcinoma by Multiregion Single-Cell Sequencing.33976164Dejima H, Hu X, Chen R, Zhang J, Fujimoto J, Parra ER, Haymaker C, Hubert SM, Duose D, Solis LM, Su D, Fukuoka J, Tabata K, Pham HHN, Mcgranahan N, Zhang B, Ye J, Ying L, Little L, Gumbs C, Chow CW, Estecio MR, Godoy MCB, Antonoff MB, Sepesi B, Pass HI, Behrens C, Zhang J, Vaporciyan AA, Heymach JV, Scheet P, Lee JJ, Wu J, Futreal PA, Reuben A, Kadara H, Wistuba II, Zhang JNature communicationsImmune evolution from preneoplasia to invasive lung adenocarcinomas and underlying molecular features. Nat Commun. 2021 05 11; 12(1):2722.Nat Commun2021-05-11T00:00:002021Immune evolution from preneoplasia to invasive lung adenocarcinomas and underlying molecular features.Authorship 1018994134015310Sepesi B, Cascone TThe Lancet. OncologyWill radiotherapy be a future part of neoadjuvant therapy in operable non-small-cell lung cancer? Lancet Oncol. 2021 06; 22(6):744-746.Lancet Oncol2021-05-18T00:00:002021Will radiotherapy be a future part of neoadjuvant therapy in operable non-small-cell lung cancer?Authorship 10200081134057733Corsini EM, Mitchell KG, Zhou N, Bernatchez C, Forget MA, Haymaker CL, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Amaria RN, Jazaeri AA, Antonoff MBJournal of surgical oncologyPulmonary resection for tissue harvest in adoptive tumor-infiltrating lymphocyte therapy: Safety and feasibility. J Surg Oncol. 2021 Sep; 124(4):699-703.J Surg Oncol2021-05-31T00:00:002021Pulmonary resection for tissue harvest in adoptive tumor-infiltrating lymphocyte therapy: Safety and feasibility.34095952Zhou N, Mitchell KG, Corsini EM, Truong VTT, Antonoff MB, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Ajani JA, Hofstetter WLThe British journal of surgeryAnalysis of trimodal and bimodal therapy in a selective-surgery paradigm for locally advanced oesophageal squamous cell carcinoma. Br J Surg. 2021 10 23; 108(10):1207-1215.Br J Surg2021-10-23T00:00:002021Analysis of trimodal and bimodal therapy in a selective-surgery paradigm for locally advanced oesophageal squamous cell carcinoma.Authorship 10249227Authorship 10253111034252403Blumenthaler AN, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Strange CD, Antonoff MBThe Annals of thoracic surgeryPreoperative Maximum Standardized Uptake Value Associated With Recurrence Risk in Early Lung Cancer. Ann Thorac Surg. 2022 06; 113(6):1835-1844.Ann Thorac Surg2021-07-09T00:00:002021Preoperative Maximum Standardized Uptake Value Associated With Recurrence Risk in Early Lung Cancer.Authorship 1026900734358522Bayley EM, Zhou N, Mitchell KG, Antonoff MB, Mehran RJ, Rice DC, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Cinciripini PM, Karam-Hage M, Roth JA, Hofstetter WLThe Annals of thoracic surgeryModern Perioperative Practices May Mitigate Effects of Continued Smoking Among Lung Cancer Patients. Ann Thorac Surg. 2022 07; 114(1):286-292.Ann Thorac Surg2021-08-03T00:00:002021Modern Perioperative Practices May Mitigate Effects of Continued Smoking Among Lung Cancer Patients.Authorship 10280342834413300Cascone T, Weissferdt A, Godoy MCB, William WN, Leung CH, Lin HY, Basu S, Yadav SS, Pataer A, Mitchell KG, Khan MAW, Shi Y, Haymaker C, Solis LM, Parra ER, Kadara H, Wistuba II, Sharma P, Allison JP, Ajami NJ, Wargo JA, Jenq RR, Gibbons DL, Lee JJ, Swisher SG, Vaporciyan AA, Heymach JV, Sepesi BNature communicationsNodal immune flare mimics nodal disease progression following neoadjuvant immune checkpoint inhibitors in non-small cell lung cancer. Nat Commun. 2021 08 19; 12(1):5045.Nat Commun2021-08-19T00:00:002021Nodal immune flare mimics nodal disease progression following neoadjuvant immune checkpoint inhibitors in non-small cell lung cancer.Authorship 1029280834494925Blumenthaler AN, Zhou N, Parikh K, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Antonoff MBInnovations (Philadelphia, Pa.)Optimizing Discharge After Shorter Hospitalizations: Lessons Learned Through After-Hours Calls with Thoracic Surgical Patients. Innovations (Phila). 2021 Nov-Dec; 16(6):529-535.Innovations (Phila)2021-09-08T00:00:002021Optimizing Discharge After Shorter Hospitalizations: Lessons Learned Through After-Hours Calls with Thoracic Surgical Patients.Authorship 10313958Authorship 10315733534653632Federico L, McGrail DJ, Bentebibel SE, Haymaker C, Ravelli A, Forget MA, Karpinets T, Jiang P, Reuben A, Negrao MV, Li J, Khairullah R, Zhang J, Weissferdt A, Vaporciyan AA, Antonoff MB, Walsh G, Lin SY, Futreal A, Wistuba I, Roth J, Byers LA, Gaudreau PO, Uraoka N, Cruz AF, Dejima H, Lazcano RN, Solis LM, Parra ER, Lee JJ, Swisher S, Cascone T, Heymach JV, Zhang J, Sepesi B, Gibbons DL, Bernatchez CAnnals of oncology : official journal of the European Society for Medical OncologyDistinct tumor-infiltrating lymphocyte landscapes are associated with clinical outcomes in localized non-small-cell lung cancer. Ann Oncol. 2022 01; 33(1):42-56.Ann Oncol2021-10-13T00:00:002021Distinct tumor-infiltrating lymphocyte landscapes are associated with clinical outcomes in localized non-small-cell lung cancer.34634240Feldman HA, Erasmus JJ, Zhou N, Antonoff MB, Mehran RJ, Rajaram R, Rice DC, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Hofstetter WL, Betancourt Cuellar SLThe Annals of thoracic surgeryClinical Significance of [18F] Fluoro-2-Deoxy-d-Glucose/Computed Tomographic Avid Hilar Lymph Nodes in Esophageal Carcinoma Patients. Ann Thorac Surg. 2022 10; 114(4):1183-1188.Ann Thorac Surg2021-10-09T00:00:002021Clinical Significance of [18F] Fluoro-2-Deoxy-d-Glucose/Computed Tomographic Avid Hilar Lymph Nodes in Esophageal Carcinoma Patients.Authorship 10337605Authorship 1033979134762869Sepesi BThe Annals of thoracic surgeryLung Cancer Surgery After Neoadjuvant Immunotherapy or Targeted Therapy: Knowledge, Judgment, and Skills Refined. Ann Thorac Surg. 2022 10; 114(4):1106-1107.Ann Thorac Surg2021-11-08T00:00:002021Lung Cancer Surgery After Neoadjuvant Immunotherapy or Targeted Therapy: Knowledge, Judgment, and Skills Refined.34740455Zorrilla-Vaca A, Rice D, Brown JK, Antonoff M, Sepesi B, Hofstetter W, Swisher S, Walsh G, Vaporciyan A, Mehran R, Hagberg C, Mena GESurgerySustained reduction of discharge opioid prescriptions in an enhanced recovery after thoracic surgery program: A multilevel generalized linear model. Surgery. 2022 02; 171(2):504-510.Surgery2021-11-02T00:00:002021Sustained reduction of discharge opioid prescriptions in an enhanced recovery after thoracic surgery program: A multilevel generalized linear model.Authorship 10350212334883083Zhou N, Hofstetter WL, Esophageal Squamous Cell Carcinoma Working Group, Mitchell KG, Bayley EM, Ajani JA, Antonoff MB, Betancourt SL, Blum-Murphy M, Feldman HA, Lin SH, Maru DM, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Weston BRThe Annals of thoracic surgerySalvage Esophagectomy Definition Influences Comparative Outcomes in Esophageal Squamous Cell Cancers. Ann Thorac Surg. 2022 12; 114(6):2032-2040.Ann Thorac Surg2021-12-06T00:00:002021Salvage Esophagectomy Definition Influences Comparative Outcomes in Esophageal Squamous Cell Cancers.34873156Tang M, Abbas HA, Negrao MV, Ramineni M, Hu X, Hubert SM, Fujimoto J, Reuben A, Varghese S, Zhang J, Li J, Chow CW, Mao X, Song X, Lee WC, Wu J, Little L, Gumbs C, Behrens C, Moran C, Weissferdt A, Lee JJ, Sepesi B, Swisher S, Cheng C, Kurie J, Gibbons D, Heymach JV, Wistuba II, Futreal PA, Kalhor N, Zhang JNature communicationsThe histologic phenotype of lung cancers is associated with transcriptomic features rather than genomic characteristics. Nat Commun. 2021 12 06; 12(1):7081.Nat Commun2021-12-06T00:00:002021The histologic phenotype of lung cancers is associated with transcriptomic features rather than genomic characteristics.Authorship 10353734Authorship 10354231034894636Zorrilla-Vaca A, Feldman H, Antonoff M, Sepesi B, Hofstetter W, Rajaram R, Swisher S, Mena G, Vaporciya A, Mehran R, Rice DThe Thoracic and cardiovascular surgeonSingle Chest Drain Practice Reduces Discharge Opioid Prescriptions in Thoracic Surgery. Thorac Cardiovasc Surg. 2022 08; 70(5):422-429.Thorac Cardiovasc Surg2021-12-11T00:00:002021Single Chest Drain Practice Reduces Discharge Opioid Prescriptions in Thoracic Surgery.34897440Bostock IC, Zhou N, Antonoff MB, Murphy MB, Lin S, Maru D, Mehran R, Rajaram R, Rice D, Sepesi B, Swisher S, Vaporciyan A, Walsh G, Hofstetter WDiseases of the esophagus : official journal of the International Society for Diseases of the EsophagusProlonged neutrophilia is associated with worse outcomes after Esophagectomy. Dis Esophagus. 2022 Apr 19; 35(4).Dis Esophagus2022-04-19T00:00:002022Prolonged neutrophilia is associated with worse outcomes after Esophagectomy.Authorship 1036601334985966Chaft JE, Shyr Y, Sepesi B, Forde PMJournal of clinical oncology : official journal of the American Society of Clinical OncologyPreoperative and Postoperative Systemic Therapy for Operable Non-Small-Cell Lung Cancer. J Clin Oncol. 2022 02 20; 40(6):546-555.J Clin Oncol2022-01-05T00:00:002022Preoperative and Postoperative Systemic Therapy for Operable Non-Small-Cell Lung Cancer.Authorship 10380965Authorship 103928121Authorship 104004722Authorship 10404216Authorship 10408701Authorship 10411783Authorship 10415391035221030Ripley RT, Mansfield AS, Sepesi B, Bueno R, Burt BMThe Journal of thoracic and cardiovascular surgeryCheckpoint blockade in unresectable pleural mesothelioma: Event horizon for multimodal therapy. J Thorac Cardiovasc Surg. 2023 01; 165(1):364-368.J Thorac Cardiovasc Surg2022-01-22T00:00:002022Checkpoint blockade in unresectable pleural mesothelioma: Event horizon for multimodal therapy.35038676Deboever N, McGrail DJ, Lee Y, Tran HT, Mitchell KG, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Bernatchez C, Vailati Negrao M, Zhang J, Wistuba II, Heymach JV, Cascone T, Gibbons DL, Haymaker CL, Sepesi BLung cancer (Amsterdam, Netherlands)Surgical approach does not influence changes in circulating immune cell populations following lung cancer resection. Lung Cancer. 2022 02; 164:69-75.Lung Cancer2022-01-08T00:00:002022Surgical approach does not influence changes in circulating immune cell populations following lung cancer resection.35110355Shah P, Forget MA, Frank ML, Jiang P, Sakellariou-Thompson D, Federico L, Khairullah R, Neutzler CA, Wistuba I, Chow CB, Long Y, Fujimoto J, Lin SY, Maitra A, Negrao MV, Mitchell KG, Weissferdt A, Vaporciyan AA, Cascone T, Roth JA, Zhang J, Sepesi B, Gibbons DL, Heymach JV, Haymaker CL, McGrail DJ, Reuben A, Bernatchez CJournal for immunotherapy of cancerCombined IL-2, agonistic CD3 and 4-1BB stimulation preserve clonotype hierarchy in propagated non-small cell lung cancer tumor-infiltrating lymphocytes. J Immunother Cancer. 2022 02; 10(2).J Immunother Cancer2022-02-01T00:00:002022Combined IL-2, agonistic CD3 and 4-1BB stimulation preserve clonotype hierarchy in propagated non-small cell lung cancer tumor-infiltrating lymphocytes.35190177Sepesi B, Zhou N, William WN, Lin HY, Leung CH, Weissferdt A, Mitchell KG, Pataer A, Walsh GL, Rice DC, Roth JA, Mehran RJ, Hofstetter WL, Antonoff MB, Rajaram R, Negrao MV, Tsao AS, Gibbons DL, Lee JJ, Heymach JV, Vaporciyan AA, Swisher SG, Cascone TThe Journal of thoracic and cardiovascular surgerySurgical outcomes after neoadjuvant nivolumab or nivolumab with ipilimumab in patients with non-small cell lung cancer. J Thorac Cardiovasc Surg. 2022 11; 164(5):1327-1337.J Thorac Cardiovasc Surg2022-01-23T00:00:002022Surgical outcomes after neoadjuvant nivolumab or nivolumab with ipilimumab in patients with non-small cell lung cancer.35267572Deboever N, Mitchell KG, Feldman HA, Cascone T, Sepesi BCancersCurrent Surgical Indications for Non-Small-Cell Lung Cancer. Cancers (Basel). 2022 Feb 28; 14(5).Cancers (Basel)2022-02-28T00:00:002022Current Surgical Indications for Non-Small-Cell Lung Cancer.35070369Bostock IC, Hofstetter W, Mehran R, Rajaram R, Rice D, Sepesi B, Swisher S, Vaporciyan A, Walsh G, Antonoff MBJournal of thoracic diseaseBarriers to surveillance imaging adherence in early-staged lung cancer. J Thorac Dis. 2021 Dec; 13(12):6848-6854.J Thorac Dis2021-12-01T00:00:002021Barriers to surveillance imaging adherence in early-staged lung cancer.35252897Antonoff MB, Feldman HA, Mitchell KG, Farooqi A, Ludmir EB, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Sepesi B, Swisher SG, Walsh GL, Gandhi S, Gomez DR, Vaporciyan AAJTO clinical and research reportsSurgical Complexity of Pulmonary Resections Performed for Oligometastatic NSCLC. JTO Clin Res Rep. 2022 Mar; 3(3):100288.JTO Clin Res Rep2022-02-04T00:00:002022Surgical Complexity of Pulmonary Resections Performed for Oligometastatic NSCLC.Authorship 104324617Authorship 10435671835394499Rocha P, Zhang J, Laza-Briviesca R, Cruz-Berm?dez A, Bota-Rabassedas N, Sanchez-Espiridon B, Yoshimura K, Behrens C, Lu W, Tang X, Pataer A, Parra ER, Haymaker C, Fujimoto J, Swisher SG, Heymach JV, Gibbons DL, Lee JJ, Sepesi B, Cascone T, Solis LM, Provencio M, Wistuba II, Kadara HClinical cancer research : an official journal of the American Association for Cancer ResearchDistinct Immune Gene Programs Associated with Host Tumor Immunity, Neoadjuvant Chemotherapy, and Chemoimmunotherapy in Resectable NSCLC. Clin Cancer Res. 2022 06 01; 28(11):2461-2473.Clin Cancer Res2022-06-01T00:00:002022Distinct Immune Gene Programs Associated with Host Tumor Immunity, Neoadjuvant Chemotherapy, and Chemoimmunotherapy in Resectable NSCLC.Authorship 1044826835489217Deboever N, Feldman HA, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Antonoff MBThe Journal of surgical researchThe Role of Surgery in the Treatment of Melanoma Pulmonary Metastases in the Modern Era. J Surg Res. 2022 09; 277:125-130.J Surg Res2022-04-27T00:00:002022The Role of Surgery in the Treatment of Melanoma Pulmonary Metastases in the Modern Era.Authorship 1046176135585121Sepesi B, Swisher SGNature reviews. Clinical oncologyRole of neoadjuvant chemoimmunotherapy for resectable NSCLC. Nat Rev Clin Oncol. 2022 08; 19(8):497-498.Nat Rev Clin Oncol2022-08-01T00:00:002022Role of neoadjuvant chemoimmunotherapy for resectable NSCLC.Authorship 10469232135640927Govindan R, Aggarwal C, Antonia SJ, Davies M, Dubinett SM, Ferris A, Forde PM, Garon EB, Goldberg SB, Hassan R, Hellmann MD, Hirsch FR, Johnson ML, Malik S, Morgensztern D, Neal JW, Patel JD, Rimm DL, Sagorsky S, Schwartz LH, Sepesi B, Herbst RSJournal for immunotherapy of cancerSociety for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lung cancer and mesothelioma. J Immunother Cancer. 2022 05; 10(5).J Immunother Cancer2022-05-01T00:00:002022Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lung cancer and mesothelioma.Authorship 10514611535884533Hong L, Lewis WE, Nilsson M, Patel S, Varghese S, Rivera MJ, Du RR, Chen P, Kemp HN, Rinsurongkawong W, Heeke S, Spelman AR, Elamin YY, Negrao MV, Sepesi B, Gibbons DL, Lee JJ, Wu J, Vokes NI, Heymach JV, Zhang J, Le XCancersLimited Benefit from the Addition of Immunotherapy to Chemotherapy in TKI-Refractory EGFR-Mutant Lung Adenocarcinoma. Cancers (Basel). 2022 Jul 17; 14(14).Cancers (Basel)2022-07-17T00:00:002022Limited Benefit from the Addition of Immunotherapy to Chemotherapy in TKI-Refractory EGFR-Mutant Lung Adenocarcinoma.Authorship 105787020Authorship 10609684Authorship 10577555Authorship 10600226Authorship 105764925Authorship 105541019Authorship 10608042Authorship 105446717Authorship 10625039Authorship 10574221235926641Mills AC, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Antonoff MBThe Annals of thoracic surgeryRepeated Pulmonary Metastasectomy: Third?Operations and Beyond. Ann Thorac Surg. 2023 03; 115(3):679-685.Ann Thorac Surg2022-08-02T00:00:002022Repeated Pulmonary Metastasectomy: Third?Operations and Beyond.35973335Akhave N, Zhang J, Bayley E, Frank M, Chiou SH, Behrens C, Chen R, Hu X, Parra ER, Lee WC, Swisher S, Solis L, Weissferdt A, Moran C, Kalhor N, Zhang J, Scheet P, Vaporciyan AA, Sepesi B, Gibbons DL, Heymach JV, Lee JJ, Wistuba II, Andrew Futreal P, Zhang J, Fujimoto J, Reuben ALung cancer (Amsterdam, Netherlands)Immunogenomic profiling of lung adenocarcinoma reveals poorly differentiated tumors are associated with an immunogenic tumor microenvironment. Lung Cancer. 2022 10; 172:19-28.Lung Cancer2022-08-10T00:00:002022Immunogenomic profiling of lung adenocarcinoma reveals poorly differentiated tumors are associated with an immunogenic tumor microenvironment.36052678Bayley EM, Ivy ML, Shewale JB, Ge PS, Antonoff MB, Francis AM, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Vaporciyan AA, Walsh GL, Lee JJ, Louie BE, Swisher SGAnnals of surgeryHigh-Risk Features of Esophageal Adenocarcinoma Following Neoadjuvant Chemoradiation: Patients for Whom Surgery Should Not Be Delayed. Ann Surg. 2023 05 01; 277(5):721-726.Ann Surg2022-09-02T00:00:002022High-Risk Features of Esophageal Adenocarcinoma Following Neoadjuvant Chemoradiation: Patients for Whom Surgery Should Not Be Delayed.36524701Shenson JA, Zafereo ME, Lee M, Contrera KJ, Feng L, Boonsripitayanon M, Gross N, Goepfert R, Maniakas A, Wang JR, Grubbs L, Vaporciyan A, Hofstetter W, Swisher S, Mehran R, Rice D, Sepesi B, Antonoff M, Cabanillas M, Busaidy N, Dadu R, Silver NLHead & neckClinical outcomes of combined cervical and transthoracic surgical approaches in patients with advanced thyroid cancer. Head Neck. 2023 03; 45(3):547-554.Head Neck2022-12-16T00:00:002022Clinical outcomes of combined cervical and transthoracic surgical approaches in patients with advanced thyroid cancer.36098652Hao D, Han G, Sinjab A, Gomez-Bolanos LI, Lazcano R, Serrano A, Hernandez SD, Dai E, Cao X, Hu J, Dang M, Wang R, Chu Y, Song X, Zhang J, Parra ER, Wargo JA, Swisher SG, Cascone T, Sepesi B, Futreal AP, Li M, Dubinett SM, Fujimoto J, Solis Soto LM, Wistuba II, Stevenson CS, Spira A, Shalapour S, Kadara H, Wang LCancer discoveryThe Single-Cell Immunogenomic Landscape of B and Plasma Cells in Early-Stage Lung Adenocarcinoma. Cancer Discov. 2022 11 02; 12(11):2626-2645.Cancer Discov2022-11-02T00:00:002022The Single-Cell Immunogenomic Landscape of B and Plasma Cells in Early-Stage Lung Adenocarcinoma.36630093Deboever N, Eisenberg M, Chidi A, Sepesi BJournal of surgical oncologyThe role of immunotherapy and targeted therapy in the multimodal therapy for resectable lung cancer. J Surg Oncol. 2023 Feb; 127(2):275-281.J Surg Oncol2023-02-01T00:00:002023The role of immunotherapy and targeted therapy in the multimodal therapy for resectable lung cancer.36590745Feldman HA, Zhou N, Deboever N, Hofstetter W, Mehran R, Rajaram R, Rice D, Roth JA, Sepesi B, Swisher S, Vaporciyan A, Walsh G, Godoy M, Strange C, Antonoff MBJTCVS openIntraoperative challenges after induction therapy for non-small cell lung cancer: Effect of nodal disease on technical complexity. JTCVS Open. 2022 Dec; 12:372-384.JTCVS Open2022-10-25T00:00:002022Intraoperative challenges after induction therapy for non-small cell lung cancer: Effect of nodal disease on technical complexity.35944232Schmidt ST, Akhave N, Knightly RE, Reuben A, Vokes N, Zhang J, Li J, Fujimoto J, Byers LA, Sanchez-Espiridion B, Diao L, Wang J, Federico L, Forget MA, McGrail DJ, Weissferdt A, Lin SY, Lee Y, Suzuki E, Kovacs JJ, Behrens C, Wistuba II, Futreal A, Vaporciyan A, Sepesi B, Heymach JV, Bernatchez C, Haymaker C, Cascone T, Zhang J, Bristow CA, Heffernan TP, Negrao MV, Gibbons DL, ICON TeamJCO clinical cancer informaticsShared Nearest Neighbors Approach and Interactive Browser for Network Analysis of a Comprehensive Non-Small-Cell Lung Cancer Data Set. JCO Clin Cancer Inform. 2022 07; 6:e2200040.JCO Clin Cancer Inform2022-07-01T00:00:002022Shared Nearest Neighbors Approach and Interactive Browser for Network Analysis of a Comprehensive Non-Small-Cell Lung Cancer Data Set.36389133Pataer A, Weissferdt A, Correa AM, Vaporciyan AA, Sepesi B, Heymach JV, Berezowska S, Cascone T, Swisher SGJTO clinical and research reportsMajor Pathologic Response and Prognostic Score Predict Survival in Patients With Lung Cancer Receiving Neoadjuvant Chemotherapy. JTO Clin Res Rep. 2022 Nov; 3(11):100420.JTO Clin Res Rep2022-09-30T00:00:002022Major Pathologic Response and Prognostic Score Predict Survival in Patients With Lung Cancer Receiving Neoadjuvant Chemotherapy.36422794Weissferdt A, Sepesi B, Ning J, Hermsen M, Ferrarotto R, Glisson B, Hanna E, Bell DCurrent oncology reportsOptimal Combination of Neuroendocrine Markers for the Detection of High-Grade Neuroendocrine Tumors of the Sinonasal Tract and Lung. Curr Oncol Rep. 2023 01; 25(1):1-10.Curr Oncol Rep2022-11-24T00:00:002022Optimal Combination of Neuroendocrine Markers for the Detection of High-Grade Neuroendocrine Tumors of the Sinonasal Tract and Lung.Authorship 1063187936737380Zhou N, Bell CS, Feldman HA, Haymaker CL, Hofstetter WL, Tsao AS, Mehran RJ, Rice DC, Sepesi B, Mesothelioma Immune Genomic GroupThe Journal of thoracic and cardiovascular surgeryTumor thickness in mesothelioma predicts differential response to neoadjuvant therapy and survival. J Thorac Cardiovasc Surg. 2023 08; 166(2):362-371.e9.J Thorac Cardiovasc Surg2022-12-14T00:00:002022Tumor thickness in mesothelioma predicts differential response to neoadjuvant therapy and survival.Authorship 10634612436755027Hong L, Aminu M, Li S, Lu X, Petranovic M, Saad MB, Chen P, Qin K, Varghese S, Rinsurongkawong W, Rinsurongkawong V, Spelman A, Elamin YY, Negrao MV, Skoulidis F, Gay CM, Cascone T, Gandhi SJ, Lin SH, Lee PP, Carter BW, Wu CC, Antonoff MB, Sepesi B, Lewis J, Gibbons DL, Vaporciyan AA, Le X, Jack Lee J, Roy-Chowdhuri S, Routbort MJ, Gainor JF, Heymach JV, Lou Y, Wu J, Zhang J, Vokes NINature communicationsEfficacy and clinicogenomic correlates of response to immune checkpoint inhibitors alone or with chemotherapy in non-small cell lung cancer. Nat Commun. 2023 02 08; 14(1):695.Nat Commun2023-02-08T00:00:002023Efficacy and clinicogenomic correlates of response to immune checkpoint inhibitors alone or with chemotherapy in non-small cell lung cancer.Authorship 10640992436788067Francisco-Cruz A, Rocha P, Reuben A, Krishnan SN, Das P, Chen R, Quek K, Li J, Parra ER, Solis LM, Barua S, Jiang M, Lazcano R, Chow CW, Behrens C, Gumb C, Little L, Fukuoka J, Kalhor N, Weissferdt A, Kadara H, Heymach JV, Swisher S, Sepesi B, Rao A, Moran C, Zhang J, Lee JJ, Fujimoto J, Futreal PA, Wistuba II, Peterson CB, Zhang JModern pathology : an official journal of the United States and Canadian Academy of Pathology, IncAnalysis of Immune Intratumor Heterogeneity Highlights Immunoregulatory and Coinhibitory Lymphocytes as Hallmarks of?Recurrence in Stage I Non-Small Cell Lung Cancer. Mod Pathol. 2023 01; 36(1):100028.Mod Pathol2023-01-01T00:00:002023Analysis of Immune Intratumor Heterogeneity Highlights Immunoregulatory and Coinhibitory Lymphocytes as Hallmarks of?Recurrence in Stage I Non-Small Cell Lung Cancer.Authorship 1064441936801207Zhou N, Niu J, Nelson D, Feldman HA, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Sepesi B, Swisher SG, Walsh GL, Giordano SH, Rajaram RThe Annals of thoracic surgerySurgical Approach and Persistent Opioid Use in Medicare Patients Undergoing Lung Cancer Resection. Ann Thorac Surg. 2023 Nov; 116(5):1020-1027.Ann Thorac Surg2023-02-16T00:00:002023Surgical Approach and Persistent Opioid Use in Medicare Patients Undergoing Lung Cancer Resection.Authorship 10656625736928818Cascone T, Leung CH, Weissferdt A, Pataer A, Carter BW, Godoy MCB, Feldman H, William WN, Xi Y, Basu S, Sun JJ, Yadav SS, Rojas Alvarez FR, Lee Y, Mishra AK, Chen L, Pradhan M, Guo H, Sinjab A, Zhou N, Negrao MV, Le X, Gay CM, Tsao AS, Byers LA, Altan M, Glisson BS, Fossella FV, Elamin YY, Blumenschein G, Zhang J, Skoulidis F, Wu J, Mehran RJ, Rice DC, Walsh GL, Hofstetter WL, Rajaram R, Antonoff MB, Fujimoto J, Solis LM, Parra ER, Haymaker C, Wistuba II, Swisher SG, Vaporciyan AA, Lin HY, Wang J, Gibbons DL, Jack Lee J, Ajami NJ, Wargo JA, Allison JP, Sharma P, Kadara H, Heymach JV, Sepesi BNature medicineNeoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial. Nat Med. 2023 03; 29(3):593-604.Nat Med2023-03-16T00:00:002023Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial.Authorship 10681529Authorship 1068036937116780Deboever N, Correa AM, Feldman H, Mathur U, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Sepesi B, Swisher SG, Walsh GL, Vaporciyan AA, Antonoff MB, Rajaram RThe Journal of thoracic and cardiovascular surgeryDisparities in early-stage lung cancer outcomes at minority-serving hospitals compared with nonminority serving hospitals. J Thorac Cardiovasc Surg. 2024 Jan; 167(1):329-337.e4.J Thorac Cardiovasc Surg2023-04-26T00:00:002023Disparities in early-stage lung cancer outcomes at minority-serving hospitals compared with nonminority serving hospitals.37080372Mitchell KG, Bayley EM, Ikoma N, Antonoff MB, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Maru DM, Erasmus JJ, Weston BR, Ajani JA, Badgwell BD, Hofstetter WLThe Annals of thoracic surgeryGastric Extent of Tumor Predicts Peritoneal Metastasis in Siewert II Adenocarcinoma. Ann Thorac Surg. 2024 Feb; 117(2):320-326.Ann Thorac Surg2023-04-18T00:00:002023Gastric Extent of Tumor Predicts Peritoneal Metastasis in Siewert II Adenocarcinoma.Authorship 10734306Authorship 10724609Authorship 10728678Authorship 107442213Authorship 10741773837306641Expert Consensus Panel, Kidane B, Bott M, Spicer J, Backhus L, Chaft J, Chudgar N, Colson Y, D'Amico TA, David E, Lee J, Najmeh S, Sepesi B, Shu C, Yang J, Swanson S, Stiles BThe Journal of thoracic and cardiovascular surgeryThe American Association for Thoracic Surgery (AATS) 2023 Expert Consensus Document: Staging and multidisciplinary management of patients with early-stage non-small cell lung cancer. J Thorac Cardiovasc Surg. 2023 09; 166(3):637-654.J Thorac Cardiovasc Surg2023-06-10T00:00:002023The American Association for Thoracic Surgery (AATS) 2023 Expert Consensus Document: Staging and multidisciplinary management of patients with early-stage non-small cell lung cancer.37268451Saad MB, Hong L, Aminu M, Vokes NI, Chen P, Salehjahromi M, Qin K, Sujit SJ, Lu X, Young E, Al-Tashi Q, Qureshi R, Wu CC, Carter BW, Lin SH, Lee PP, Gandhi S, Chang JY, Li R, Gensheimer MF, Wakelee HA, Neal JW, Lee HS, Cheng C, Velcheti V, Lou Y, Petranovic M, Rinsurongkawong W, Le X, Rinsurongkawong V, Spelman A, Elamin YY, Negrao MV, Skoulidis F, Gay CM, Cascone T, Antonoff MB, Sepesi B, Lewis J, Wistuba II, Hazle JD, Chung C, Jaffray D, Gibbons DL, Vaporciyan A, Lee JJ, Heymach JV, Zhang J, Wu JThe Lancet. Digital healthPredicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study. Lancet Digit Health. 2023 Jul; 5(7):e404-e420.Lancet Digit Health2023-05-31T00:00:002023Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study.37356476Deboever N, Eisenberg MA, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Rajaram RThe Journal of thoracic and cardiovascular surgeryPerspectives, risk factors, and coping mechanisms in patients with self-reported financial burden following lung cancer surgery. J Thorac Cardiovasc Surg. 2024 Feb; 167(2):478-487.e2.J Thorac Cardiovasc Surg2023-06-24T00:00:002023Perspectives, risk factors, and coping mechanisms in patients with self-reported financial burden following lung cancer surgery.37249193Deboever N, Eisenberg M, Hofstetter WL, Mehran RJ, Rice DC, Roth J, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Antonoff MB, Rajaram RAnnals of surgeryFinancial Toxicity in Patients With Resected Lung Cancer. Ann Surg. 2023 12 01; 278(6):1038-1044.Ann Surg2023-05-30T00:00:002023Financial Toxicity in Patients With Resected Lung Cancer.37451404Lee JM, McNamee CJ, Toloza E, Negrao MV, Lin J, Shum E, Cummings AL, Kris MG, Sepesi B, Bara I, Kurtsikidze N, Schulze K, Ngiam C, Chaft JEJournal of thoracic oncology : official publication of the International Association for the Study of Lung CancerNeoadjuvant Targeted Therapy in Resectable NSCLC: Current and Future Perspectives. J Thorac Oncol. 2023 11; 18(11):1458-1477.J Thorac Oncol2023-07-13T00:00:002023Neoadjuvant Targeted Therapy in Resectable NSCLC: Current and Future Perspectives.Authorship 1075637937495170Deboever N, Bayley EM, Eisenberg MA, Hofstetter WL, Mehran RJ, Rice DC, Rajaram R, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Bednarski BK, Morris VK, Antonoff MBThe Journal of thoracic and cardiovascular surgeryLung surveillance following colorectal cancer pulmonary metastasectomy: Utilization of clinicopathologic risk factors to guide strategy. J Thorac Cardiovasc Surg. 2024 Mar; 167(3):814-819.e2.J Thorac Cardiovasc Surg2023-07-24T00:00:002023Lung surveillance following colorectal cancer pulmonary metastasectomy: Utilization of clinicopathologic risk factors to guide strategy.Authorship 10787519Authorship 107895922Authorship 107836532Authorship 1079037937619884Deboever N, Mitchell KG, Farooqi A, Ludmir EB, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Heymach JV, Gomez DR, Gandhi SJ, Antonoff MBThe Journal of thoracic and cardiovascular surgeryPerioperative and oncologic outcomes of pulmonary resection for synchronous oligometastatic non-small cell lung cancer: Evidence for surgery in advanced disease. J Thorac Cardiovasc Surg. 2023 Aug 22.J Thorac Cardiovasc Surg2023-08-22T00:00:002023Perioperative and oncologic outcomes of pulmonary resection for synchronous oligometastatic non-small cell lung cancer: Evidence for surgery in advanced disease.37702631Dacic S, Travis W, Redman M, Saqi A, Cooper WA, Borczuk A, Chung JH, Glass C, Lopez JM, Roden AC, Sholl L, Weissferdt A, Posadas J, Walker A, Zhu H, Wijeratne MT, Connolly C, Wynes M, Bota-Rabassedas N, Sanchez-Espiridion B, Lee JJ, Berezowska S, Chou TY, Kerr K, Nicholson A, Poleri C, Schalper KA, Tsao MS, Carbone DP, Ready N, Cascone T, Heymach J, Sepesi B, Shu C, Rizvi N, Sonett J, Altorki N, Provencio M, Bunn PA, Kris MG, Belani CP, Kelly K, Wistuba I, IASLC Pathology CommitteeJournal of thoracic oncology : official publication of the International Association for the Study of Lung CancerInternational Association for the Study of Lung Cancer Study of Reproducibility in Assessment of Pathologic Response in Resected Lung Cancers After Neoadjuvant Therapy. J Thorac Oncol. 2023 10; 18(10):1290-1302.J Thorac Oncol2023-09-12T00:00:002023International Association for the Study of Lung Cancer Study of Reproducibility in Assessment of Pathologic Response in Resected Lung Cancers After Neoadjuvant Therapy.37637041Deboever N, Zhou N, McGrail DJ, Tomczak K, Oliva JL, Feldman HA, Parra E, Zhang J, Lee PP, Antonoff MB, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Roth JA, Swisher SS, Vaporciyan AA, Altan M, Weissferdt A, Tsao AS, Haymaker CL, Sepesi BFrontiers in oncologyRadiographic response to neoadjuvant therapy in pleural mesothelioma should serve as a guide for patient selection for cytoreductive operations. Front Oncol. 2023; 13:1216999.Front Oncol2023-08-11T00:00:002023Radiographic response to neoadjuvant therapy in pleural mesothelioma should serve as a guide for patient selection for cytoreductive operations.37696428Eisenberg MA, Deboever N, Mills AC, Egyud MR, Hofstetter WL, Mehran RJ, Rice DC, Rajaram R, Sepesi B, Swisher SG, Walsh GL, Vaporciyan AA, Antonoff MBThe Journal of thoracic and cardiovascular surgeryImpact of travel distance on receipt of indicated adjuvant therapy in resected non-small cell lung cancer. J Thorac Cardiovasc Surg. 2023 Sep 09.J Thorac Cardiovasc Surg2023-09-09T00:00:002023Impact of travel distance on receipt of indicated adjuvant therapy in resected non-small cell lung cancer.Authorship 1080972237816395Feldman H, Sepesi B, Leung CH, Lin H, Weissferdt A, Pataer A, William WN, Walsh GL, Rice DC, Roth JA, Mehran RJ, Hofstetter WL, Antonoff MB, Rajaram R, Gibbons DL, Lee JJ, Heymach JV, Vaporciyan AA, Swisher SG, Cascone TThe Journal of thoracic and cardiovascular surgerySurgical outcomes after chemotherapy plus nivolumab and chemotherapy plus nivolumab and ipilimumab in patients with non-small cell lung cancer. J Thorac Cardiovasc Surg. 2024 Apr; 167(4):1444-1453.e4.J Thorac Cardiovasc Surg2023-10-08T00:00:002023Surgical outcomes after chemotherapy plus nivolumab and chemotherapy plus nivolumab and ipilimumab in patients with non-small cell lung cancer.Authorship 1081738437844869Weissferdt A, Leung CH, Lin H, Sepesi B, William WN, Swisher SG, Cascone T, Lee JJ, Pataer AModern pathology : an official journal of the United States and Canadian Academy of Pathology, IncPathologic Processing of Lung Cancer Resection Specimens After Neoadjuvant Therapy. Mod Pathol. 2024 Jan; 37(1):100353.Mod Pathol2023-10-14T00:00:002023Pathologic Processing of Lung Cancer Resection Specimens After Neoadjuvant Therapy.Authorship 1082692937876311Deboever N, Bayley EM, Eisenberg MA, Hofstetter WL, Mehran RJ, Rice DC, Rajaram R, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Bednarski BK, Morris VK, Antonoff MBJournal of surgical oncologyDo resected colorectal cancer patients need early chest imaging? Impact of clinicopathologic characteristics on time to development of pulmonary metastases. J Surg Oncol. 2024 Feb; 129(2):331-337.J Surg Oncol2023-10-24T00:00:002023Do resected colorectal cancer patients need early chest imaging? Impact of clinicopathologic characteristics on time to development of pulmonary metastases.Authorship 1083352137923289Sepesi B, Mehran R, Spicer J, Cascone TThe Journal of thoracic and cardiovascular surgeryNEOSTAR trial and the current status of neoadjuvant therapy in non-small cell lung cancer. J Thorac Cardiovasc Surg. 2023 Nov 01.J Thorac Cardiovasc Surg2023-11-01T00:00:002023NEOSTAR trial and the current status of neoadjuvant therapy in non-small cell lung cancer.Authorship 10842018Authorship 10839451237969292Deboever N, Eisenberg M, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Roth J, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Antonoff MBJournal of thoracic diseaseCirculomic variables predict pathologic staging preoperatively in treatment-na?ve non-small cell lung cancer. J Thorac Dis. 2023 Oct 31; 15(10):5507-5516.J Thorac Dis2023-10-20T00:00:002023Circulomic variables predict pathologic staging preoperatively in treatment-na?ve non-small cell lung cancer.37992871Tran HT, Heeke S, Sujit S, Vokes N, Zhang J, Aminu M, Lam VK, Vaporciyan A, Swisher SG, Godoy MCB, Cascone T, Sepesi B, Gibbons DL, Wu J, Heymach JVAnnals of oncology : official journal of the European Society for Medical OncologyCirculating tumor DNA and radiological tumor volume identify patients at risk for relapse with resected, early-stage non-small-cell lung cancer. Ann Oncol. 2024 Feb; 35(2):183-189.Ann Oncol2023-11-21T00:00:002023Circulating tumor DNA and radiological tumor volume identify patients at risk for relapse with resected, early-stage non-small-cell lung cancer.Authorship 10891984Authorship 1089352938391198Deboever N, Feldman H, Eisenberg M, Antonoff MB, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Hofstetter WLDiseases of the esophagus : official journal of the International Society for Diseases of the EsophagusOctreotide's role in the management of post-esophagectomy chylothorax. Dis Esophagus. 2024 Feb 22.Dis Esophagus2024-02-22T00:00:002024Octreotide's role in the management of post-esophagectomy chylothorax.38378398Pilon Y, Rokah M, Seitlinger J, Sepesi B, Rayes RF, Cools-Lartigue J, Najmeh S, Sirois C, Mulder D, Ferri L, Abdulkarim B, Ezer N, Fraser R, Camilleri-Bro?t S, Fiset PO, Wong A, Sud S, Langleben A, Agulnik J, Pepe C, Shieh B, Hirsh V, Ofiara L, Owen S, Spicer JDClinical lung cancerTransitioning to Neoadjuvant Therapy for Resectable Non-Small Cell Lung Cancer: Trends and Surgical Outcomes in a Regionalized Pulmonary Oncology Network. Clin Lung Cancer. 2023 Dec 19.Clin Lung Cancer2023-12-19T00:00:002023Transitioning to Neoadjuvant Therapy for Resectable Non-Small Cell Lung Cancer: Trends and Surgical Outcomes in a Regionalized Pulmonary Oncology Network.Authorship 10898442438418883Han G, Sinjab A, Rahal Z, Lynch AM, Treekitkarnmongkol W, Liu Y, Serrano AG, Feng J, Liang K, Khan K, Lu W, Hernandez SD, Liu Y, Cao X, Dai E, Pei G, Hu J, Abaya C, Gomez-Bolanos LI, Peng F, Chen M, Parra ER, Cascone T, Sepesi B, Moghaddam SJ, Scheet P, Negrao MV, Heymach JV, Li M, Dubinett SM, Stevenson CS, Spira AE, Fujimoto J, Solis LM, Wistuba II, Chen J, Wang L, Kadara HNatureAn atlas of epithelial cell states and plasticity in lung adenocarcinoma. Nature. 2024 Mar; 627(8004):656-663.Nature2024-02-28T00:00:002024An atlas of epithelial cell states and plasticity in lung adenocarcinoma.Authorship 10904201338471502Salehjahromi M, Karpinets TV, Sujit SJ, Qayati M, Chen P, Aminu M, Saad MB, Bandyopadhyay R, Hong L, Sheshadri A, Lin J, Antonoff MB, Sepesi B, Ostrin EJ, Toumazis I, Huang P, Cheng C, Cascone T, Vokes NI, Behrens C, Siewerdsen JH, Hazle JD, Chang JY, Zhang J, Lu Y, Godoy MCB, Chung C, Jaffray D, Wistuba I, Lee JJ, Vaporciyan AA, Gibbons DL, Gladish G, Heymach JV, Wu CC, Zhang J, Wu JCell reports. MedicineSynthetic PET from CT improves diagnosis and prognosis for lung cancer: Proof of concept. Cell Rep Med. 2024 Mar 19; 5(3):101463.Cell Rep Med2024-03-11T00:00:002024Synthetic PET from CT improves diagnosis and prognosis for lung cancer: Proof of concept.Authorship 109088624Authorship 10914271438499683Han G, Sinjab A, Rahal Z, Lynch AM, Treekitkarnmongkol W, Liu Y, Serrano AG, Feng J, Liang K, Khan K, Lu W, Hernandez SD, Liu Y, Cao X, Dai E, Pei G, Hu J, Abaya C, Gomez-Bolanos LI, Peng F, Chen M, Parra ER, Cascone T, Sepesi B, Moghaddam SJ, Scheet P, Negrao MV, Heymach JV, Li M, Dubinett SM, Stevenson CS, Spira AE, Fujimoto J, Solis LM, Wistuba II, Chen J, Wang L, Kadara HNatureAuthor Correction: An atlas of epithelial cell states and plasticity in lung adenocarcinoma. Nature. 2024 Mar 18.Nature2024-03-18T00:00:002024Author Correction: An atlas of epithelial cell states and plasticity in lung adenocarcinoma.38512301Sorin M, Prosty C, Ghaleb L, Nie K, Katergi K, Shahzad MH, Dub? LR, Atallah A, Swaby A, Dankner M, Crump T, Walsh LA, Fiset PO, Sepesi B, Forde PM, Cascone T, Provencio M, Spicer JDJAMA oncologyNeoadjuvant Chemoimmunotherapy for NSCLC: A Systematic Review and Meta-Analysis. JAMA Oncol. 2024 Mar 21.JAMA Oncol2024-03-21T00:00:002024Neoadjuvant Chemoimmunotherapy for NSCLC: A Systematic Review and Meta-Analysis.true1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1Assistant ProfessorAssistant Professortrue1Assistant ProfessorAssistant Professortrue1ProfessorProfessortrue1ProfessorProfessor